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Zusammenfassung 
Der ubiquitin-abhängige Proteinabbau durch das Proteasom ist die Hauptquelle von Peptiden 
für die MHC Klasse I Antigen-Präsentation. In Vertebraten kann das Proteasomsystem durch 
die Expression unterschiedlicher Subtypen des 20S Proteasoms moduliert werden. Die 
häufigsten Subtypen sind konstitutive Proteasomen (c20S) mit den katalytischen 
Untereinheiten ?1, ?2 und ?5 und Immunoproteasomen (i20S) mit den Immunountereinheiten 
?1i, ?2i und ?5i. Die Expression von i20S kann eine Verbesserung der MHC Klasse I 
Antigen-Präsentation bewirken, indem die Bildung von Peptiden mit hoher Affinität zu MHC 
I Molekülen verstärkt wird.  
Laut dem aktuellen Stand der Forschung wird die Bildung von i20S durch kooperative 
Assemblierung reguliert, die auf der präferentiellen Interaktion zwischen den 
Immunountereinheiten beruht. In dieser Arbeit wurde die Assemblierung von 20S 
Proteasomen in ?5i defizienten Mäusen (lmp7-/- Mäuse) im Laufe einer Infektion mit Listeria 
monocytogenes analysiert. In diesem Modell konnte keine präferentielle Interaktion zwischen 
konstitutiven bzw. Immunountereinheiten festgestellt werden. Stattdessen zeigen die 
Ergebnisse, daß die Integration von konstitutiven oder Immuno-Untereinheiten während der 
Proteasomassemblierung durch Kompetition reguliert wird. Desweiteren wurde während der 
Infektion eine Zunahme der zellulären Proteasommenge in Wildtyp-Mäusen festgestellt, die 
in lmp7
-/-
 Mäusen nicht auftritt. Damit konnte ein neuer Mechanismus zur Regulation des 
zellulären Proteasomgehaltes gezeigt werden, der über die differentielle Expression von ?5i 
gesteuert wird. 
Funktionell führt die ?5i-Defizienz zu einer verringerten MHC I Oberflächendichte auf 
antigenpräsentierenden Zellen und zu einer stark verminderten Prozessierung des bakteriellen 
Antigens LLO296-304. Bei der Analyse der LLO296-304 spezifischen CD8 T Zell Antwort konnte 
jedoch kein Unterschied zwischen Wildtyp- und lmp7
-/-
 Mäusen festgestellt werden .Die 
Kontrolle der Infektion in den lmp7
-/-
 Mäusen ist jedoch in der Leber verzögert. Dies deutet 
darauf hin, dass die Erkennung und Elimination infizierter Zellen durch cytotoxische CD8 T 
Zellen auf Grund der geringeren MHC Klasse I Präsentation bakterieller Antigene behindert 
wird. 
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Abstract 
The ubiquitin-dependent protein degradation by proteasomes is the main source of peptides 
for MHC class I antigen presentation. In vertebrates the proteasome-system can be modulated 
by the expression of different subtypes of the 20S proteasome. The most common subtypes 
are constitutive proteasomes (c20S) with the catalytic subunits ?1, ?2 and ?5 and 
immunoproteasomes (i20S) with the immunosubunits ?1i, ?2i and ?5i. Expression of i20s can 
lead to an improvement of MHC class I antigen presentation by increasing the generation of 
peptides with high affinity to MHC class I molecules.  
Currently, the formation of i20S is thought to be regulated by cooperative proteasome 
assembly, a principle that is based on the preferential interaction among the immunosubunits. 
Here, the assembly of 20S proteasomes was analysed in ?5i deficient mice (lmp7-/- mice) 
during an ongoing infection with the intracellular bacterium Listeria monocytogenes. In this 
model, no preferential interactions among constitutive subunits or immunosubunits could be 
determined. Instead, the results show that the integration of constitutive subunits or 
immunosubunits is regulated by direct competition during proteasome assembly. Further, an 
increase in cellular proteasome quantity was observed in infected wild-type mice, that was 
absent in lmp7
-/-
 mice. This finding reveals a novel mechanism for the regulation of cellular 
proteasome quantity that is based on the differential expression of ?5i.  
Functionally, the deficiency in ?5i results in a reduced MHC class I cell surface expression on 
professional antigen presenting cells and a drastically diminished processing of the bacterial 
antigen LLO296-304. However, the analyses of LLO296-304 specific CD8 T cells did not reveal 
differences in the frequencies of these T cells between wild-type and lmp7
-/-
 mice. Still, the 
control of infection in the liver of lmp7
-/-
 mice was delayed. This phenotype suggests that the 
recognition and elimination of infected target cells by cytotoxic CD8 T cells is constrained 
due to the low MHC class I presentation of bacterial antigens. 
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1 Introduction 
 
1.1 The proteasome system 
 
Proteasomes are found in all three domains of life: prokaryots, archaea and eukaryots. They 
are multimeric protein complexes with varying complexity that possess protein-hydrolyzing 
activity. While proteasomes may not be important for survival of prokaryotic cells, their 
function is crucial for the survival of eukaryotic cells (Baumeister, et al., 1998). They are 
localized in the nucleus and the cytosol and can make up to 1% of cellular protein content 
(Gerards, et al., 1998).  
Besides their housekeeping function in protein turnover and disposal of damaged proteins, 
they are involved in a variety of cellular processes, e.g. cell cycle control, apoptosis, 
transcriptional regulation, protein translation, chromatin remodelling, DNA repair and MHC 
class I antigen presentation. (Baugh and Pilipenko, 2004; Baumeister, et al., 1998; Chang, et 
al., 1998; Coux, et al., 1996; Goldberg, et al., 2002; King, et al., 1996) 
 
1.1.1 The ubiquitin-proteasome pathway 
 
The major pathway of non-lysomal protein degradation in eukaryotic cells is the ubiquitin-
proteasome pathway (Rock, et al., 1994). It is an energy dependent pathway, which involves a 
complex ubiquitin ligation system and the function of 26S proteasomes. Besides the disposal 
of damaged proteins, this pathway regulates the cellular content of certain proteins and by that 
modulates their activity (Kornitzer and Ciechanover, 2000).  
Covalent ligation of ubiquitin marks proteins for targeted degradation by proteasomes. 
Ubiquitin is a highly conserved protein of 76 amino acids. The linkage of ubiquitin to its 
target protein requires three catalytic steps. First, ubiquitin needs to be activated at its 
carboxy-terminal (C-terminal) glycine residue in an ATP dependent step by a specific 
activating enzyme, E1. This step involves formation of an intermediate complex in which 
ubiquitin is bound to a cysteine residue of E1 via a thiolesther linkage. Thereafter, ubiquitin is 
transferred to a cysteine residue in the active site of an ubiquitin-carrier protein, E2. Finally, a 
ubiquitin ligase, E3, takes up ubiquitin from E2 and catalyses an amide isopeptide linkage of 
the C-terminal glycine of ubiquitin to an ?-amino group of the target protein (Kornitzer and 
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Ciechanover, 2000). While usually only one E1 is expressed, various species of E2 and 
multiple families of E3 exist. The E3 proteins confer substrate specificity either by direct 
binding to a substrate or due to recruitment by other proteins (Hershko and Ciechanover, 
1998). 
Once a target protein is marked by ubiquitin, polyubiquitin chains form by further ligation of 
ubiquitins to a specific lysine residue, most commonly Lys
48
. The resulting 
polyubiquitinylated proteins are recognized by 26S proteasomes by binding to UBA 
(ubiquitin associated domains) or UBL (ubiquitin like) domains. This is followed by 
deubiquitination of the substrate, which is necessary for ubiquitin recycling. Subsequently, the 
target protein is unfolded and translocated into the proteasome complex where it is hydrolized 
to peptides. It is still unclear, which steps require ATP in this process. However, the protein 
hydrolysis itself is energy independent. Thus, ATP is thought to be necessary for substrate 
unfolding, translocation and deubiquitination (Demartino and Gillette, 2007; Hershko and 
Ciechanover, 1998). 
 
1.1.2 Proteasome structure 
 
The variety of proteasome complexes found within eukaryotic cells is based on a central 20S 
core that is bound to different regulators. The 20S core is composed of two identical 16S half-
proteasomes. Each half proteasome contains 14 different subunits, which can be grouped in 
?- or ?-type subunits by sequence homology. The particular subunits ?1-?7 and ?1-?7 are 
arranged in heptameric ?- and ?-rings, respectively. In the 20S complex two 16S complexes 
form a barrel-shaped structure built of two central ?-rings and two outer ?-rings (Coux, et al., 
1996; Groll, et al., 1997). Inside this cylinder three cavities are formed: two antechambers 
between the ?- and ?-rings of each 16S half and the central cavity between the two adjacent 
?-rings. As a mechanism of self-compartementalization, substrate access to the proteolytically 
active sites in the central cavity is gated by narrow channels, which enables controlled protein 
degradation (Baumeister, et al., 1998).  
Each ?-ring contains three catalytically active subunits. An amino-terminal (N-terminal) 
threonine residue is essential for peptide hydrolysis by a nucleophilic attack (Arendt and 
Hochstrasser, 1997; Chen and Hochstrasser, 1996; Dick, et al., 1997; Kisselev, et al., 1999; 
Schmidtke, et al., 1996).  
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In mammals, two major forms of 20S proteasomes can be distinguished according to the 
incorporated catalytic ?-subunits. The constitutive proteasome (c20S) contains the 
constitutive subunits ?1 (Y), ?2 (Z) and ?5 (X). By the use of fluorogenic peptide substrates 
caspase-like (peptidylglutamyl peptide hydrolizing), trypsin-like and chymotrypsin-like 
activity could be assigned to ?1, ?2 and ?5, respectively (Groll, et al., 1997). Following IFN? 
stimulation, mammalian cells express the immunosubunits ?1i (LMP2), ?2i (MECL1) and ?5i 
(LMP7) (Glynne, et al., 1991; Groettrup, et al., 1996; Hisamatsu, et al., 1996; Nandi, et al., 
1996). Incorporation of these subunits results in the formation of immunoproteasomes (i20S), 
which display increased chymotrypsin-like and reduced caspase-like activity compared to 
c20S. i20S reveal altered cleavage site specificity, which is commonly thought to improve 
MHC class I antigen presentation (Groettrup, et al., 2001).  
20S proteasomes associate with different types of regulators, which can be bound to either 
one or both endplates of the outer ?-rings. Generally, they are thought to control access to the 
active sites of the 20S complex inside the central cavity (Baumeister, et al., 1998).  
The most abundant regulator of proteasomes is the 19S complex (PA700), which in 
combination with the 20S complex forms the 26S proteasome. As described previously, the 
26S proteasome is the central enzymatic complex of the ubiquitin-proteasome pathway 
(Hershko and Ciechanover, 1998). 19S complexes include at least 15 different subunits. Six 
of these are ATPases, which form a hexameric ring that is in direct contact with the ?-ring of 
the 20S complex. The exact ATP consuming steps catalized by these proteins are not 
identified, but are most likely associated with substrate unfolding, control of substrate access, 
product release and substrate translocation through the cavities of the 20S complex. Some of 
the non-ATPase subunits recognize polyubiquitinated substrates and bind them for 
degradation via UBA or UBL domains. Other components possess deubiquitinating activity 
and cleave polyubiquitin conjugates of the target proteins for ubiquitin recycling (Baumeister, 
et al., 1998; Coux, et al., 1996).  
The 11S regulator (PA28) is described as an ATP independent activator of proteasomes, 
which accelerates the peptidase activity of 20S complexes (Dubiel, et al., 1992). However, it 
does not stimulate the degradation of ubiquitinated proteins. It is a multimer composed of the 
IFN? inducible subunits PA28? and PA28? (Realini, et al., 1994). It is thought that 11S 
regulators open the entry in the ?-ring, thus improving substrate access to and product release 
from the catalytic centre of the 20S complex (Stohwasser, et al., 2000). 
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Further, the formation of so-called hybrid proteasomes, which contain a 19S regulator and an 
11S regulator at opposing sites of the 20S complex, were described. As they combine the 
ability of the 19S complex to degrade ubiquitinated substrates with increased substrate 
turnover by the 11S regulator, they are discussed as optimal complexes in protein processing 
(Tanahashi, et al., 2000). 
Additional regulators increase the complexity of the proteasome system. PA28?, whose 
regulation is unknown, forms a homoheptamer, that similar to 11S complexes binds to the ?-
ring. Although the exact function is not clear, PA28? deficiency in mice results in a growth 
defect and increased susceptibility to apoptosis. In addition, PA200 can accelerate proteasome 
activity by opening the occlusions of the ?-rings at the 20S complex. It has been associated 
with DNA repair and cellular stress responses. In contrast, PI31 and Pr39 down-modulate the 
activity of the proteasome by replacing the activating regulators and obstructing the substrate 
access (Demartino and Gillette, 2007).  
 
1.1.3 Proteasome assembly 
 
The neogenesis of the 20S proteasome with its 28 subunits involves a series of consecutive 
events of which the initial steps remain largely elusive (Schmidt, et al., 1997). Recently, the 
proteasome assembling chaperones, PAC1, PAC2, PAC3 and PAC4, have been identified in 
mammalian cells. They provide a molecular scaffold, which facilitates the correct formation 
of a complete ?-ring. The proteins PAC1 and PAC2 as well as PAC3 and PAC4 form 
heterodimers, respectively. While PAC1/PAC2 is bound to the ?-ring until formation of the 
20S complex is completed, PAC3/PAC4 dissociates of the assembling complex during 16S 
half proteasome formation (Fig. I A-B). The PAC proteins are not degraded during 
proteasome neogenesis indicating that they can be recycled (Hirano, et al., 2006; Hirano, et 
al., 2005; Le Tallec, et al., 2007). 
The ?-subunits use the ?-ring as a matrix and are assembled in a sequential manner. First, the 
early subunits ?2 or ?2i, ?3, ?4 and ?1i are bound resulting in an intermediate 13S complex. 
This is followed by the integration of the residual subunits ?1, ?5 or ?5i, ?6 and ?7, which 
leads to the formation of a 16S half proteasome (Nandi, et al., 1997) (Fig. I B).  
The proteasome maturation factor POMP (proteassemblin/ Ump1p/ hUmp1) is a component 
of 13-16S complexes (Burri, et al., 2000; Griffin, et al., 2000). Recently, it was shown that 
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POMP interacts with most ?-subunits and some ?-subunits, indicating that it recruits the ?-
subunits to the ?-ring. Further, POMP binds to endoplasmatic reticulum (ER) membranes and 
by that promotes coordinated proteasome formation at the ER (Fricke, et al., 2007). In 
addition, it mediates the assembly of two 16S complexes to a 20S proteasome and is therefore 
essential for the maturation of proteasomes (Fig. I B-C). After completion of assembly it 
becomes the initial substrate, thus POMP turnover is an indicator for the rate of proteasome 
neogenesis (Heink, et al., 2005; Ramos, et al., 1998; Witt, et al., 2000).  
 
 
Figure I. Schematic diagramm of the consecutive steps in proteasome assembly 
The diagramm schematically illustrates the consecutive steps in proteasome assembly and the known factors 
involved in this process. ?-subunits are displayed in light grey, structural ?-subunits in dark grey. The catalytic 
?-subunits, irrespective if immuno- or constitutive subunits are depicted in blue. 
 
 
With the exeption of ?3 and ?4, the ?-subunits are integrated as precursor subunits with N-
terminal propeptides. The prosequence protects the N-terminal threonine residue of the 
catalytic subunits from chemical modifications, which is essential to maintain their catalytic 
activity (Arendt and Hochstrasser, 1999). The prosequences of the proteolytic subunits are 
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autocatalytically cleaved while the residual ?-subunits are most likely processed by the 
adjacent catalytic subunits (Chen and Hochstrasser, 1996; Schmidtke, et al., 1996). The 
maturation of precursor ?-subunits occurs in 13-16S complexes and is completed upon 
formation of 20S proteasomes (Frentzel, et al., 1994). This prevents premature proteolytic 
activity until self-compartmentalization of the active sites in the cavity of the 20S core is 
achieved (Baumeister, et al., 1998). 
Further, information within the sequence of propeptides facilitates efficient integration into 
20S proteasomes. While deletion of the ?1i-propeptide still allows integration of ?1i, the 
addition of charged residues to the prosequence inhibits its integration (Schmidt, et al., 1999). 
The propeptides of ?2 and ?2i were shown to provide differential integration efficiency to 
their carrying subunits. Especially the ?2i-propeptide improved the integration when fused to 
?2 (De, et al., 2003). Similar results were obtained, when the propeptides of ?5 and ?5i were 
exchanged. While fusion of ?5i improves the integration of ?5, the combination of the ?5-
propeptide with ?5i diminishes its integration (Kingsbury, et al., 2000). Although deletion of 
the ?5i-prosequence still allows integration of ?5i, maturation of proteasomes is impaired 
(Witt, et al., 2000). In summary, these findings underline the importance of the propeptides in 
the regulation of proteasome assembly.  
Following the assembly of 20S proteasomes various regulators, which have been described 
above, bind to the endplates of the ?-rings (Fig I C).  
Interestingly, the rate of 20S proteasome assembly is not constant. Recently, it was shown 
that expression of ?5i accelerates the rate of proteasome neogenesis (Heink, et al., 2005). 
Further, treatment of cells with irreversible proteasome inhibitors induces the concerted 
expression of proteasomal subunits to allow rapid regeneration of the proteasome pool 
(Meiners, et al., 2003). This is achieved by activation of the Nrf2-Keap1 signalling pathway, 
which leads to enhanced transcription of most proteasomal subunit genes via antioxidative 
response elements (ARE) in their promoters (Kwak, et al., 2002). 
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1.1.4 Regulation of proteasome composition 
  
Despite the theoretical possibility of multiple combinations of constitutive and 
immunosubunits, the most abundant forms of 20S proteasomes are c20S or i20S. According 
to current opinion, formation of c20S or i20S is achieved by cooperative assembly of 
constitutive or immunosubunits, respectively. In this model, ?5 preferentially interacts with 
?1 and ?2 containing precursor proteasomes resulting in c20S, while ?5i predominantly pairs 
with ?1i and ?2i to form i20S (Fig. II). 
The cooperative model of proteasome assembly is based on observations in T2 cells, which 
carry a deletion in the MHC class II locus covering the genes lmp2 and lmp7 encoding for ?1i 
and ?5i, respectively. Following reconstitution of T2 cells with lmp2 but not lmp7, pre-?1i 
and pre-?2i accumulate in precursor proteasomes. This finding suggests that ?5i is crucial for 
efficient maturation of ?1i and ?2i containing proteasomes, while ?5 integrates only 
inefficiently into these complexes. The specific interaction of immunosubunits is thought to 
be an intrinsic function of their propeptides (De, et al., 2003; Kingsbury, et al., 2000). In 
conclusion, formation of mixed proteasomes (m20S) with ?1i/?2i/?5 or ?1/?2/?5i 
stoichiometry is supposed to be a rare event (Griffin, et al., 1998) (Fig. II). Cooperative 
integration was further shown for ?1i and ?2i, which mutually facilitate their integration into 
20S proteasomes (Groettrup, et al., 1997).  
By now the stringent model of cooperative proteasome assembly has been enervated due to 
the identification of various proteasome subtypes with combinations of constitutive and 
immunosubunits. However, the formation of m20S with ?1i/?2i/?5 stoichiometry is still 
regarded as highly inefficient (De, et al., 2003; Drews, et al., 2007; Kingsbury, et al., 2000; 
Klare, et al., 2007). 
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Figure II. Model of cooperative proteasome assembly  
Schematic model of proteaome assembly according to Griffin et al., 1998. Constitutive subunits are coloured in 
green, immunosubunits in red. Specific integration of ?5 into ?1 and ?2 containing precursor proteasomes 
results in formation of c20S, while ?5i predominantly integrates into ?1i and ?2i containing precursor 
complexes forming i20S. However, formation of m20S is a rare event indicated by dotted arrows.  
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1.2 The function of proteasomes in the immune response 
 
1.2.1 The MHC class I pathway of antigen presentation 
 
The function of the major histocompatibility class I (MHC class I) pathway of antigen 
presentation is to allow the discrimination between immunological self and non-self. The 
peptide array presented by MHC class I molecules on the cell surface is scanned by CD8
+
 T 
cells via their T cell receptor (TCR). Presentation of foreign or tumor antigens results in the 
rapid elimination of the respective cells by CD8
+
 T cells (Elliott, 2006). The ubiquitin-
proteasome pathway is the major source of peptides for MHC class I antigen presentation 
(Rock, et al., 1994). Thus, the peptides for MHC class I presentation usually arise from 
cytosolic proteins. An important source of peptides is defective ribosomal products (DRiPs), 
which summarize abnormal protein products resulting from defective translation, RNA 
splicing, folding or posttranslational modification. The use of DRiPs as a source of peptides 
couples antigen presentation with protein neosynthesis, which is believed to assure rapid 
presentation of new antigens, e.g. following viral infections (Yewdell, et al., 2001).  
Peptides suitable for MHC class I presentation are translocated into the ER by the transporter 
associated with antigen presentation (TAP). Inside the ER lumen, the TAP complex is 
associated with the peptide loading complex, which contains the chaperones tapasin, 
calreticulin and ERp57 (Rock and Goldberg, 1999). 
The MHC I molecule is a heterodimer consisting of a heavy chain and a ?2-microglobulin 
(?2M). Assembly of this heterodimer is achieved by the action of the chaperones calnexin or 
BiP (immunglobulin binding protein) and ERp57. Upon association of the MHC class I heavy 
chain with ?2M calnexin is exchanged against calreticulin resulting in the peptide loading 
complex. MHC class I molecules associated to the peptide loading complex bind to the TAP 
complex via interaction with tapasin. Binding of a fitting peptide to the MHC binding grove 
stabilizes the MHC class I molecule, which is than transported to the cell surface (Antoniou, 
et al., 2003). 
However, the peptides presented by this pathway have to comply with the requirements of the 
TAP complex and the structure of MHC class I molecules. The TAP complex preferentially 
transports peptides of 7-15 amino acids (Rock and Goldberg, 1999). Dependending on the 
haplotype of MHC class I molecules, binding is restricted to peptides of 8-10 amino acids 
(Rammensee, et al., 1993). Two defined anchor residues within the peptide sequence 
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additionally determine the stability of peptide binding to the MHC binding grove. Especially 
at the C-terminus of an epitope, exclusively basic or hydrophobic amino acids are accepted as 
anchor residues (Heemels and Ploegh, 1995).  
The peptides generated by 26S proteasomes have a size range of 4-20 amino acids, of which 
less than 15% have the correct size for MHC class I binding (Kisselev, et al., 1999). 
Proteasomes usually generate the correct C-terminus of an epitope and the majority of 
peptides is produced as N-terminally extended precursors (Cascio, et al., 2001). These 
precursor epitopes are subjected to post-proteasomal processing either in the cytosol or the ER 
(Rock, et al., 2004). The cytosolic tripeptidylpeptidase II (TPPII) is involved in this trimming 
process, because it acts as an exoprotease that cleaves tripeptides from the N-terminus (Reits, 
et al., 2004). In addition, TPPII can directly process antigens by its endoproteolytic activity 
and thus complements proteasome function (Kloetzel, 2004; Seifert, et al., 2003). In the ER, 
especially the ER aminopeptidase 1 (ERAP1) is responsible for trimming of precursor 
epitopes (York, et al., 2002).  
An important mechanism in MHC class I presentation is cross-presentation of particulate or 
extracellular antigens on professional antigen presenting cells (APCs), e.g. derived from 
apoptotic cells, which are initially taken up by phagocytosis. Although phagolysosomes are 
equipped with multiple proteases themselves, efficient cross-presentation of antigens on MHC 
class I molecules involves the transfer of proteasome substrates to the cytosol (Norbury, et al., 
2004). The Sec61 translocon, which is found in phagolysosomal membranes following fusion 
with ER membranes, is involved in such retrograde transport of proteasomal substrates 
(Ploegh, 2004). Consequently, cross-presentation involves the classical MHC class I pathway 
of antigen presentation. 
Besides the classical MHC class I pathway described above, formyl-methione containing 
peptides are presented by non-classical MHC class Ib molecules such as H2M3 in mice. 
These peptides are directly released into the cytosol by pathogenic bacteria and are 
independent of further processing. They directly enter the ER via the TAP complex, where 
they are bound to empty MHC class Ib molecules, which are stored in the ER due to a lack of 
endogenous peptides (Pamer, 2004). Presentation of bacterial antigens on MHC class Ib 
molecules plays a crucial role in early adaptive immune responses (Kerksiek, et al., 1999; 
Seaman, et al., 2000).  
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1.2.2 The influence of proteasome composition on epitope 
processing 
 
The MHC class I pathway of antigen presentation is a remarkably inefficient process. As 
already described, less than 15% of peptides generated by 26S proteasomes have the correct 
size of 8-10 amino acid residues for MHC class I binding. Although N-terminally extended 
precursor epitopes can be processed to proper CD8
+
 T cell epitopes, most of them are 
degraded to free amino acids by other aminopeptidases in the cytosol before they reach the 
ER lumen. Further, the enzymes involved in antigen processing can also destroy epitopes by 
unspecific cleavages. Consequently, less than 0.01% percent of the generated epitopes are 
presented on MHC class I molecules on the cell surface (Yewdell, et al., 2003). Indeed, the 
activity of proteasomes was shown to be limiting for MHC class I presentation (Benham and 
Neefjes, 1997). 
The expression of ?1i, ?2i and ?5i and subsequent formation of i20S is generally believed to 
improve the efficiency of MHC class I presentation. In agreement with this, ?1i and ?5i are 
encoded in the MHC class II locus adjacent to the genes of TAP, suggesting a role in antigen 
presentation (Glynne, et al., 1991). Accordingly, replacement of constitutive subunits by 
immunosubunits modifies the specificity and activity of 20S proteasomes: 
Replacement of ?1 by ?1i especially reduces the caspase-like activity and thus limits the 
amount of peptides with acidic C-termini that are incompatible with the MHC class I binding 
grove. Instead, integration of ?1i enhances the chymotrypsin-like activity, which results in the 
generation of peptides with hydrophobic C-termini optimal for MHC class I binding 
(Groettrup, et al., 2001).  
The impact of the exchange of ?2 by ?2i is unclear. Both subunits possess trypsin-like 
activity, which produces peptides with basic C-termini, necessary for the generation of some 
CD8
+
 T cell epitopes. Overexpression of an catalytically inactive ?2i subunit results in 
complete loss of trypsin-like activity (Salzmann, et al., 1999). However, the trypsin-like 
activity in mecl1
-/-
 mice is unaltered compared to WT mice, showing that ?2 can completely 
substitute for ?2i (Basler, et al., 2006).  
Overexpression of ?5i increases the chymotrypsin-like and the trypsin-like activity, indicating 
enhanced substrate turnover by the resulting proteasomes and consequently improved MHC 
class I presentation (Gaczynska, et al., 1994). In agreement with this finding, the MHC class I 
surface density on various cell types of lmp7
-/-
 mice was found to be 25-50% reduced due to a 
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lack of generated epitopes (Fehling, et al., 1994). Further, lmp7
-/-
 cells present a substantially 
different peptide repertoire on MHC class I molecules suggesting that the presence of ?5i 
modifies epitope quantity and quality (Toes, et al., 2001). In addition, Heink et al. 
demonstrated that expression of ?5i increases the rate of proteasome neogenesis enabling 
rapid formation of i20S in infection and inflammation (Heink, et al., 2005). These findings 
collectively underline the special importance of this immunosubunit for efficient MHC class I 
antigen presentation.  
In summary, these observations suggests that immunosubunits are adapted to the requirements 
of MHC class I presentation. Indeed, processing of a variety of CD8
+
 T cell epitopes is 
substantially facilitated in the presence of i20S (Kuckelkorn, et al., 2002; Sijts, et al., 2000; 
Sijts, et al., 2000; Strehl, et al., 2006; Toes, et al., 2001; Van den Eynde and Morel, 2001).  
In contrast, some tumor- and subdominant viral epitopes are also destroyed by the action of 
i20S while others are not affected by the proteasome composition at all (Basler, et al., 2004; 
Chapiro, et al., 2006; Kloetzel, 2001; Morel, et al., 2000). Still, the increased output of 
epitopes with hydrophobic and basic C-termini strongly suggests that i20S improve the 
processing of the majority of CD8
+
 T cell epitopes. This is not only caused by increased 
substrate turnover, but also by modified cleavage site specificity. Accordingly, it was shown 
for some epitopes that i20S can specifically increase the rate of cleavages, which result in the 
correct C-terminus of an epitope, while destructive cleavages within an epitope are reduced 
(Strehl, et al., 2008). In conclusion, i20S facilitate MHC class I presentation by enhanced 
quantity and quality of CD8
+
 T cell epitopes. 
Besides i20S, the expression of the 11S regulator increases the overall peptidase activity of 
proteasomes irrespective of the subunit composition of the associated 20S complex. As the 
maximal proteasome activity remains unaffected by 11S regulators, it is suggested that they 
accelerate substrate access and product release (Groettrup, et al., 1996; Schwarz, et al., 2000; 
Stohwasser, et al., 2000). However, the 11S complex can also specifically improve the 
processing of some CD8
+
 T cell epitopes without affecting substrate turnover (Dick, et al., 
1997; van Hall, et al., 2000).  
In summary, the IFN? inducible i20S and 11S regulators cooperatively improve epitope 
processing especially in infection and inflammation. Further, they are constitutively expressed 
in lymphoid tissues, especially in professional APCs, which is commonly thought to assure 
optimal MHC class I antigen presentation (Kuckelkorn, et al., 2002; Li, et al., 2001; 
Macagno, et al., 1999; Macagno, et al., 2001). 
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1.2.3 Function of CD8+ T cells 
 
The MHC class I restricted CD8
+
 T cells represent a major arm of the adaptive immune 
response. Their main function is the recognition of infected or tumor cells. The specific 
recognition of antigenic epitopes is mediated by the TCR, which is a heterodimer of a ?- and 
?- or ?? and ?- chain. The diversity of TCRs is achieved by random rearrangement of a 
variety of gene segments encoding fragments of the different chains (Janeway, et al., 2001). 
The education of immature T cells occurs in the thymus by positive and negative selection. T 
cells that can bind with low affinity to self-antigens presented by thymic cortical epithelial 
cells are positively selected. In contrast, T cells that strongly react against self-antigens 
presented on medullary thymic epithelial cells, thymic dendritic cells (DCs) or Macrophages 
(M?) are deleted. T cells that survive the thymic selection process egress to the periphery and 
contribute to the T cell repertoire that can react against foreign antigens (von Boehmer, et al., 
2003).  
Naive CD8
+
 T cells reside within peripheral lymphoid tissues, until they encounter a foreign 
antigen presented on activated, professional APCs like DCs or M?. The combination of TCR 
stimulation and costimulatory signals activates naive CD8
+
 T cells. Following activtion, they 
start to proliferate and develop into cytotoxic CD8
+
 effector T cells, a process known as T cell 
priming. Important costimulatory signals are provided by CD28 or CD137-ligand on CD8
+
 T 
cells binding to CD80/CD86 (B7.1/B7.2) or CD137 on the APCs (Shedlock, et al., 2003; 
Whitmire and Ahmed, 2000). The proliferation is driven by the secretion of Interleukin 2 (IL-
2) and simultaneous upregulation of IL-2-receptor, which results in autocrine stimulation 
(Wong and Pamer, 2004).  
Further, priming results in down-regulation of the adhesion molecule CD62L (L-selectin) and 
the chemokine receptor CCR7, which retain naive CD8
+
 T cells in the lymphoid 
compartment. Consequently, CD8
+
 effector T cells egress to the periphery where they detect 
infected or inflamed tissues by recognition of adhesion molecules, such as ICAM-1 or 
VCAM-1, on endothelial cells. Due to these danger signals they adhere to the endothelium 
and transmigrate from the blood vessels into the infected or inflamed tissue (Weninger, et al., 
2002). 
When CD8
+
 effector T cells recognize their cognate antigen on infected or tumor cells, they 
can mediate cytolysis by two distinct mechanisms. First, by secretion of cytotoxic granules, 
which contain the pore-forming perforin and proteolytic granzymes. On the one hand this 
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induces uncontrolled ion leakage and on the other hand the transferred granzymes activate 
caspases, which leads to apoptosis of the target cell. The second mechanism induces apoptosis 
by Fas/Fas-ligand interactions between CD8
+
 T cells and the target cell. Lysis of infected 
target cells exposes intracellular pathogens to the extracellular space, where they can be 
attacked by innate defence mechanisms. Further, apoptosis of target cells allows cross-
presentation by professional APCs and subsequent cross-priming of more CD8
+
 T cells. In 
addition, activated CD8
+
 effector T cells secrete IFN? and TNF?, which promote 
inflammation resulting in enhanced recruitment of lymphocytes (Janeway, et al., 2001).  
Although a variety of epitopes of a given antigen are presented to CD8
+
 T cells, the majority 
reacts against a few selected epitopes, a phenomenon described as immunodominance. 
Among these few epitopes the response is skewed to a large fraction of CD8
+
 T cells that 
react against one or two immunodominant epitopes, while few CD8
+
 T cells are directed 
against subdominant epitopes resulting in a defined immunodominance hierarchy. 
Immunodominance is influenced by many factors: The stability of a given peptide MHC class 
I complex; the efficiency of antigen-processing, the strength of the TCR-MHC class I 
interaction, the frequency of naive CD8
+
 T cells in the T cell repertoire and suppression of 
subdominant by immunodominant T cell responses (Chen, et al., 2000; Yewdell and Bennink, 
1999). 
 
1.2.4 The impact of proteasome subunit composition on CD8+ T-
cell responses 
 
Efficient CD8
+
 T cell priming and expansion requires a certain treshold of MHC class I 
antigen presentation on professional APCs. Beyond that treshold, the magnitude of the CD8
+
 
T cell response is largely independent of antigen quantity (Vijh, et al., 1998; Wong and 
Pamer, 2003). Further, the kinetics with which an antigen is presented on the cell surface 
critically influences priming of CD8
+
 T cells (Badovinac, et al., 2002; Mercado, et al., 2000; 
Williams and Bevan, 2004). Both, quantity as well as processing kinetics of an antigen is 
influenced by the proteasome subunit composition as described previously. Different 
proteasome types were also shown to be involved in thymic selection, indicating that 
proteasomes already influence early CD8
+
 T cell development (Murata, et al., 2007; Nil, et 
al., 2004).  
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Experiments with immunosubunit deficient mice confirmed that proteasome composition 
influences the development of CD8
+
 T cell responses in vivo. Alterations in the CD8
+
 T cell 
repertoire due to differential thymic selection have been detected in mecl1
-/-
, lmp2
-/-
 and  
lmp7
-/-
 mice (Basler, et al., 2006; Chen, et al., 2001; Osterloh, et al., 2006; Toes, et al., 2001). 
Further, differences in immunodominance hierachies of CD8
+
 T cells responding to viral 
infections were found in lmp2
-/-
 and lmp7
-/-
 mice (Chen, et al., 2001; Nussbaum, et al., 2005; 
Robek, et al., 2007).  
In addition, impaired priming and expansion of CD8
+
 T cells directed against i20S dependent 
epitopes was recently reported in immunosubunit deficient mice (Deol, et al., 2007; 
Palmowski, et al., 2006; Robek, et al., 2007). However, CD8
+
 T cell responses directed 
against some of the examined epitopes were unaffected by immunosubunit deficieny (Chen, 
et al., 2001; Deol, et al., 2007; Nussbaum, et al., 2005). In conclusion, this indicates that 
immunosubunit deficiency specifically affects CD8
+
 T cell responses directed against 
epitopes whose processing is dependent on i20S activity. Further, this suggests that the 
activity of i20S can, but must not necessarily, be critical to achieve the treshold of antigen 
presentation required for efficient CD8
+
 T cell priming. 
Although these reports focused on the analysis of CD8
+
 T cell responses, the impact of 
immunosubunit deficiency on control of infections was rarely determined. Only for the 
lymphocytic choriomeningitis virus (LCMV) it was shown, that viral clearance is not affected 
in lmp2
-/-
 and lmp7
-/-
 mice (Nussbaum, et al., 2005). However, the influence of proteasome 
subunit composition on control of a bacterial infection that depends on the action of CD8
+
 T 
cells, like Listeria monocytogenes, has not been considered so far.  
 
1.2.5 The infection model of Listeria monocytogenes 
 
Listeria monocytogenes (Listeria) is a gram-positive bacterium known as a food borne 
pathogen in humans. Infection of mice is a well characterized model of systemic bacterial 
infection (Pamer, 2004).  
Listeria can enter their host cells by expression of the surface proteins internalin A (InlA) and 
internalin B (Inl B). While InlA binds to epithelial cadherin (E-cadherin) and promotes entry 
into epithelial cells, InlB interacts with the hepatocyte growth factor receptor for invasion of 
hepatocytes. Once taken up by a cell, Listeria express the major virulence factor Listeriolysin 
O (LLO), which disrupts the phagosomal membrane and allows the bacteria to escape into the 
Introduction  21 
cytosol, where they start to replicate. Further, they express the actin-assembly-inducing 
protein A (ActA). ActA utilizes Actin of the host cell and mediates transport of the bacteria to 
neighbouring cells. By this mechanism Listeria can spread from cell to cell, without being 
exposed to the extracellular space (Pamer, 2004). 
Following intravenous (i.v.) infection, the majority of Listeria are filtered from the 
bloodstream in the liver. Extracellular bacteria are initially bound to Kupffer cells, the tissue 
resident M? of the liver, and are subsequently killed by immigrating neutrophils (Gregory, et 
al., 1996). Listeria, that survived the early innate immune defence invade hepatocytes, in 
which they start to replicate. However, activation of Kupffer cells and neutrophils results in 
the release of proinflammatory cytokines such as IL-1, IL-6, IL-12 and TNF? as well as nitric 
oxide (NO). This results in lymphocyte recruitment to the site of infection. Among infiltrating 
lymphocytes, NK and NKT cells are activated by the cytokine milieu as well as bacterial 
components and consequently secrete IFN? (Cousens and Wing, 2000; Ranson, et al., 2005). 
IFN?, IL-6 and TNF? synergistically induce  the NADPH oxidase p47phox in hepatocytes 
resulting in the production of reactive oxygene intermediates (ROI) (Gregory and Wing, 
1993; Szalay, et al., 1995). Further, IFN? activates infiltrating M?, which subsequently 
secrete reactive nitrogen intermediates (RNI) produced by the inducible nitric oxide synthase 
(iNOS) (MacMicking, et al., 1995).  
In spleen and lymph nodes, Listeria are predominantly taken up by M? and DCs (Conlan and 
North, 1994). Besides activated M?, a population of TNF? and iNOS producing DCs 
(TipDCs) was found to exert substantial antilisterial activity in the spleen (Serbina, et al., 
2003).  
In summary, the oxidative burst restricts the replication of Listeria in liver and spleen, which 
consequently reaches a plateau 3-4 days after infection until onset of adaptive immunity 
(Gregory, et al., 1992; Mackaness, 1962).  
The adaptive immune response against Listeria is of the T helper type 1 (Th1) phenotype. 
Secretion of IL-12, IL-18 and IFN? by cells of the innate immune system is responsible for 
the polarization of naive, MHC class II restricted CD4
+
 T cells to the Th1 phenotype (Seki, et 
al., 2000). CD4
+
 Th1 cells secrete IFN?, which contributes to the activation of CD8+ effector 
T cells. The CD8
+
 T cell response can be devided in two overlapping waves; the MHC class 
Ib restricted and the classical MHC class I restricted CD8
+
 T cells.  
The MHC class Ib restricted CD8
+
 T cells represent an early arm of adaptive immunity, 
important for the early control of Listeria 3-7 days post infection. Three dominant n-formyl-
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methionine containing peptides presented on the MHC class Ib molecule H2M3 are 
recognized by those CD8
+
 cells (Kerksiek, et al., 1999; Seaman, et al., 2000).  
In contrast, the classical MHC class I restricted CD8
+
 T cell response peaks 7-10 days 
following infection with Listeria. They are crucial for the complete irradication of infected 
cells from the tissue. The major antigens for MHC class I restricted CD8
+
 T cells are derived 
from the secreted proteins LLO and murein hydrolase p60 (Pamer, 2004). In mice with the 
H2
b
 haplotypic background, the CD8
+
 T cell response is distributed against a variety of 
epitopes with no clear immunodominance hierarchy. However, among these, the strongest 
CD8
+
 T cell response is elicited against the epitope LLO296-304 (Geginat, et al., 2001). 
Previously, we demonstrated that efficient processing of this epitope depends on the specific 
activity of i20S (Strehl, et al., 2006). 
  
1.2.6 Putative influences of the proteasome subunit composition 
on innate immune defence mechanisms  
 
Transcription factors of the NF-?B family are central regulators of innate and inflammatory 
immune responses, as they control the expression of proinflammatory cytokines, chemokines, 
costimulatory and adhesion molecules. Activation of NF-?B is a two-step process, which 
involves degradation of the inhibitory I?B proteins and processing of the NF-?B precursors 
p105 or p100 to the mature subunits p50 or p52, respectively. This allows the formation of 
active NF-?B heterodimers (p65/p50, cRel/p50 or RelB/p52), which enter the nucleus and 
activate gene transcription. The I?Bs and the NF-?B precursors are targeted for degradation 
by ubiquitination. Accordingly, 26S proteasomes are involved in both steps of NF-?B 
activation (Bonizzi and Karin, 2004). However, it has also been shown that 20S proteasomes 
can cleave I?B or p105 independent of ubiquitination (Alvarez-Castelao and Castano, 2005; 
Moorthy, et al., 2006). Especially the chymotryptic activity is essential for efficient 
processing of p105 and degradation of I?B? by 20S proteasomes (Petrof, et al., 2004). Thus it 
is conceivable that i20S with their increased chymotrypsin-like activity facilitate NF-?B 
activation. Indeed, it was reported in different model systems that i20S can promote NF-?B 
activation (Fitzpatrick, et al., 2006; Hayashi and Faustman, 1999; Hayashi and Faustman, 
2000; Visekruna, et al., 2006).  
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1.3 Aims of this study 
 
The subunit composition of the 20S proteasome strongly influences its activity and 
specificity. Consequently, cells lacking IFN? inducible subunits generate different peptide 
pools presented by MHC class I molecules, which can have functional consequences for 
CD8
+
 T cell responses. The aim of this study is to analyse the structural and functional impact 
of ?5i-deficiency in lmp7-/- mice during Listeria monocytogenes infection. 
 
It is suggested that ?5i is crucial for the efficient maturation of ?1i and ?2i containing 
precursor proteasomes. Due to this model of cooperative proteasome assembly it is claimed 
that the integration of ?1i and ?2i in lmp7-/- mice is largely aborted. (Fig.II) (Griffin, et al., 
1998; Kingsbury, et al., 2000). In contrast, integration of ?1i and ?2i in proteasomes of lmp7-/- 
splenocytes has been observed previously (Stohwasser, et al., 1996), but the rate of their 
integration has not been analysed in detail. Thus, major aims of this study regarding the 
structural analysis of proteaomes are: 
 
- Quantitative and qualitative analysis of the maturation of ?1i and ?2i in lymphoid and 
non-lymphoid tissues of lmp7
-/-
 mice infected with Listeria; 
- Determination of the actual impact of ?5i deficieny on proteasome maturation in vivo. 
 
In addition, the functional consequences of ?5i-deficiency on antilisterial immunity were 
analyzed. Our previous work demonstrated, that efficient generation and consequently 
presentation of the Listeriolysin O derived MHC class I epitope LLO296-304 depends on the 
presence of i20S (Strehl, et al., 2006). Hence, we expect that processing of this model epitope 
is impaired in lmp7
-/-
 mice. As reduced antigen presentation can affect priming and expansion 
of CD8
+ 
T cells as well as recognition of infected target cells, we aimed to investigate:  
 
- Processing of the LLO296-304 epitope by 20S proteasomes isolated from lmp7
-/-
 mice; 
- the LLO296-304 specific CD8
+
 T cell response in lmp7
-/-
 mice; 
- the impact of ?5i-deficiency on bacterial control during the course of Listeria 
infection. 
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2 Material and Methods 
2.1 Methods 
2.1.1 Mice 
2.1.1.1 Breeding of mice 
Mice were kept under special pathogen free conditions (spf) with a 12 h day light cycle. 
C57Bl6/N mice were obtained from Elevage Janvier (Le Genest Saint Isle, France). 
Homozygous colonies of lmp7
-/-
 mice on C57Bl6/N background and 129Ola WT mice were 
bred at the animal breeding facility of the Max Planck Institute for Infection Biology (MPIIB, 
Berlin-Marienfelde, Germany). lmp7
-/-
 mice on 129Ola background and breeding pairs of 
lmp7
-/-
 mice on C57Bl6/N background were kindly provided by Prof. Dr. Hans Joerg Schild 
(Johannes Gutenberg University, Mainz, Germany) 
 
2.1.1.2 Infection of mice with Listeria monocytogenes 
For the maintenance of bacterial virulence, infection stocks of Listeria monocytogenes EGD 
(Listeria) were generated by passage through C57Bl6/N mice. Briefly, mice were infected 
intravenously (i.v.) with 5 x 10
3
 colony forming units (cfu) of Listeria and sacrificed two days 
later. Spleens were homogenized and inoculated in Tryptic Soy Broth at 37°C. Listeria were 
grown to a density of 1-2 x 10
8 
cfu/ml; aliquots were frozen in liquid nitrogen and stored at     
-80°C. CFU counts were determined by plating serial dilutions on Palcam Agar Plates 
according to van Netten et al., 1989 (Merck, Darmstadt, Germany). For infection experiments, 
Listeria stocks were thawed and diluted in 1x phosphate buffered saline (PBS). 8-16 weeks 
old male mice were i.v. infected via the tail vein with 1-5 x 10
3
 cfu of Listeria in a volume of 
200 ?l. The infection experiments were performed at the S2 animal facility of the MPIIB 
(Berlin-Mitte, Germany). 
 
2.1.1.3 Determination of bacterial titers 
Following infection with Listeria, mice were sacrificed by cervical dislocation. Organs were 
homogenized in 1 ml sterile icecold PBS. 10fold serial dilutions were plated on Palcam Agar 
Plates according to van Netten et al. and incubated at 37°C. Bacterial colonies were counted 
24-48 h later.  
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2.1.2 Cell culture 
2.1.2.1 Phoenix E cells 
Phoenix E cells, for ecotrophic packaging of retroviral vector constructs, were kept in 
Dubelcos Modified Eagle Medium (DMEM, Gibco, Carlsbad, CA, USA) with 10% fetal calf 
serum (FCS), 1 mM L-Glutamin, 1 mM Sodium-Pyruvate, 1x Pencillin/Streptomycin solution 
(Gibco). For passaging, cells were trypsinized in 1x Trypsin-EDTA solution (Gibco). 
 
2.1.2.2 Preparation of murine embryonic fibroblasts (MEFs) 
13-14 days old embryos were decapitated and inner organs were removed. The residual tissue 
was minced in 10 ml 1x trypsin-EDTA solution (Gibco) and incubated for 15 min at 37°C. 
Then, pieces of tissue were dissociated by pipetting. 15 ml of fresh 1x trypsin-EDTA solution 
were added and cells were incubated for another 15 min at 37°C. Following incubation, the 
residual peaces of tissue were dispersed and the resulting cell solution was transferred to a 
50 ml reaction tube. 20 ml of D10 medium (DMEM (Gibco), 10% FCS, 1 mM L-Glutamin, 
1 mM Sodium-Pyruvat, 1x Pencillin/Streptomycin solution (Gibco) were added and cells 
were sedimented by centrifugation at 1500 rpm for 5 min. The supernatant was discarded, 
cells were washed in 20 ml D10 medium and centrifuged at 1500 rpm for 5 min. 1 x 10
7
 cells 
were seeded in a 150 cm
2
 tissue culture flask in D10 medium and kept in a 37°C incubator 
with 5% CO2. Medium was renewed the next day to remove non-adherent cells. MEFs were 
passaged by trypsinization in 1x trypsin EDTA solution. Spontanious immortalization of 
MEFs was achieved by frequent passaging. Following 16-18 passages the MEFs were 
regarded as immortalized cell lines.  
 
2.1.2.3 Preparation of bone-marrow derived macrophages (BM-M?) 
Femurae and tibiae were prepared from 10-16 week old male mice. The bones were washed in 
70% ethanol for 1 min to kill attached cells, before they were put in D10 medium. Then, the 
epiphyses were cut off and the bone marrow was flushed out in 1x PBS with a syringe. Bone-
marrow cells were resuspended to a single cell solution and centrifuged for 5 min at 1500 
rpm. Subsequently, bone marrow cells were resuspended in BM-M? medium (DMEM 
(Gibco), 10% FCS, 5% horse serum, 20% cell culture supernatant of macrophage colony 
stimulating factor (M-CSF) producing L929-CSF cells (MPIIB, Berlin, Germany), 1 mM L-
Glutamine, 1 mM Sodium-Pyruvate, 1x Penicillin/Streptomycin solution). 5 x 10
6
 bone 
marrow cells were seeded per cell culture dish with 10 cm diameter in 10 ml BM-M? medium 
and incubated at 37°C, 5% CO2. After 5 days 5 ml of fresh BM-M? medium were added per 
cell culture dish. Following 7-8 days of culture in BM-M? medium the bone marrow cells 
were differentiated into BM-M?.  
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2.1.3 Biochemical methods 
2.1.3.1 Preparation of organ lysates 
Murine organs frozen in liquid nitrogen were homogenzid to powder with mortar and pestle. 
An equal volume of Native Lysis Buffer (1x NativePAGE? Sample Buffer (Invitrogen, 
Carlsbad, CA, USA), 0,5% DDM, 0,2 mM Sodium Vanadate, 5 mM Sodium Fluoride, 1 mM 
PMSF, 1 mM Pefabloc? SC (Roche Applied Science, Mannheim, Germany), 1x Complete 
protease inhibitor cocktail (Roche Applied Science)) or Lysis Buffer (20 mM Tris HCl 
pH 7,2, 50 mM NaCl, 1 mM EDTA, 1 mM NaN3, 1 mM DTT, 0,1% Nonidet P40, 0,2 mM 
Sodium Vanadate, 5 mM Sodium Fluoride, 1 mM PMSF, 1 mM Pefabloc? SC (Roche 
Applied Science), 1x Complete protease inhibitor cocktail (Roche Applied Science)) was 
added for 2D Two colour Fluorescent Western Blot analysis or Two colour Fluorescent 
Western Blot analysis, respectively. Samples were mixed until the powder was thawed. 
Following three freeze thaw cycles with freezing in liquid nitrogen and thawing on ice, 
samples were centrifuged for 30 min at 13.000 rpm and 4°C in a Microfuge. For Two colour 
Fluorescent Western Blot analysis supernatants were aliquoted, frozen in liquid nitrogen and 
stored at -80°C for further use. Supernatants for 2D Two colour Fluorescent Western Blot 
analysis were centrifuged for another 20 min at 50.000 rpm and 4°C. The clear supernatants 
were frozen in liquid nitrogen. The protein concentration in the lysates was measured with 
Protein-Assay solution (Bio-Rad, Hercules, CA, USA) according to manufacturers 
instructions against a standard row of bovine serum albumin (BSA). 
 
2.1.3.2 Preparation of cell lysates 
MEFs were harvested by trypsinization and washed in icecold 1x PBS. Sedimented cells were 
resuspended in icecold Lysis Buffer (see 2.1.3.1). Following three freeze thaw cycles with 
freezing in liquid nitrogen and thawing on ice, cellular debris was sedimented for 30 min at 
13.000 rpm and 4°C in a Microfuge. The cleared supernatants were frozen in liquid nitrogen 
and stored at -80°C. The protein concentration in the lysates was measured with Protein-
Assay solution (Bio-Rad, Hercules, CA, USA) according to manufacturer`s instructions 
against a standard row of bovine serum albumin (BSA). 
 
2.1.3.3 Two Colour Fluorescent Western Blot analysis 
25-50 ?g total protein per lane of organ lysates and 10-25 ?g per lane of cell lysates 
denaturated in 1x Laemmli Buffer were seperated by SDS-PAGE. Tris-Glycine buffered 
SDS-polyacrylamide gels with 5% stacking gel and 15% resolving gel according to 
(Laemmli, 1970) were used. Gels were run in Tris-Glycine Running Buffer (25 mM Tris, 
250 mM Glycine, 0,1% (w/v) SDS) at 10-15 V/cm for 70-90 min. Following SDS-PAGE 
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proteins were transferred to Immobilon-FL PVDF (Millipore, Billerica, MA, USA) or 
nitrocellulose membrane (Pierce, Rockford, IL, USA) with 0,45 ?m poresize by 
electroblotting. Protein transfer was performed in a Mini Transblot Cell (Biorad) at 400 mA 
in Transfer Buffer (50 mM Tris, 40 mM Glycine, 0,037% (w/v) SDS, 20% (v/v) Methanol) 
for 70 min at 4°C. Following protein-transfer, membranes were blocked in Odyssey Blocking 
Reagent (Licor Bioscience, Lincoln, NE, USA) for 1 h at room temperature or at 4°C over 
night. Then, membranes were successively stained with rabbit or chicken polyclonal 
antibodies against proteasomal subunits or POMP; mouse monoclonal GAPDH-antibodies as 
a loading control; anti-rabbit IgG AlexaFluor680 or anti-chicken IgG IrDye700 conjugated 
secondary antibodies, respectively, and at last with anti-mouse IgG IrDye800 labelled 
secondary antibodies. All antibodies were diluted in Odyssey Blocking Reagent at an assay 
depend dilution (see 2.2.1) and incubated for 1 h at room temperature or over night at 4°C. 
Membranes were washed thrice for 5 min with 1x PBS, 0.05% Tween20 following each 
staining. In the end membranes were scanned with the Odyssey? Infrared Imaging system 
(Licor Biosciences). AlexaFluor680 and IrDye700 conjugated secondary antibodies were 
detected in the 700 nm channel (red signals) and IrDye800 conjugated secondary antibodies in 
the 800 nm channel (green signals). Densitometric analysis was performed with the 
Odyssey? Image Analyser Software Vers.1.2 (Licor Biosciences). Normalized band 
intensities were calculated by deviding the band intensity of the analysed protein through the 
band intensity of the loading control GAPDH.  
 
2.1.3.4 2D Two Colour Fluorescent Western Blot analysis 
In the first dimension, protein complexes were separated by Blue Native PAGE according to 
(Camacho-Carvajal, et al., 2004). Briefly, 50-100 ?g total protein per lane of organ lysates in 
1x Native Lysis Buffer (see 2.1.3.1) supplemented with 0,125% (v/v) NativePAGE? G-250 
Sample Additive (Invitrogen) were loaded on NativePAGE? Novex 4-16% Bis-Tris Gels 
(Invitrogen). Gels were run in an XCell SureLock? Mini-cell (Invitrogen) with 1x 
NativePAGE? Running Buffer (Invitrogen) as Anode Buffer and 1x Dark-Blue Cathode 
Buffer (1x NativePAGE? Running Buffer, 1x Cathode Buffer Additive (Invitrogen)). 
Following 30 min of electrophoresis at 150 V, the Dark-Blue Cathode Buffer was exchanged 
against the Light-Blue Cathode Buffer (1x NativePAGE? Running Buffer, 0.1x Cathode 
Buffer Additive) and gels were run for another 60 min. Following electrophoresis, gels were 
sliced into single lanes. For the second dimension, the protein complexes were denaturated by 
equilibration of the gel slices in 2x Laemmli Buffer (Laemmli, 1970) for 30 min at room 
temperature. Subsequently, the gel slices were placed in a preparative slot of a SDS-PAGE 
with 5% stacking and 15% resolving gel. SDS-PAGE, protein transfer to Immobilon-FL 
PVDF membranes and blocking was performed as described previously (see 2.1.3.3). All 
membranes were stained against proteasome subunit ?3 with a mouse monoclonal antibody 
(Calbiochem, Darmstadt, Germany) and IrDye800 conjugated anit-mouse IgG secondary 
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antibodies. As ?3 is a component of early to late proteasome complexes this staining indicates 
the positions of different proteasome complexes according to their separation in the first 
dimension. Further, membranes were stained against other proteasomal subunits and POMP 
with rabbit or chicken polyclonal antibodies (see 2.2.1) and anti-rabbit IgG AlexaFluor680 or 
anti-chicken IgG IrDy700 labelled secondary antibodies, respectively. Staining of membranes 
was performed as described previously (2.1.3.3). In the end, membranes were scanned and 
evaluated with the Odyssey? Infrared Imaging system (Licor Biosciences). 
 
2.1.3.5 Coimmunoprecipitation analysis 
WT MEFs stably overexpressing ?5 or ?5i with a C-terminal Flag-tag (DYKDDDDK) were 
generated by retroviral transduction (see 2.1.4.4-2.1.4.6). WT MEFs transduced with an 
empty vector construct were used as a negativ control. The MEFs were either left untreated or 
cultured for 4 days in the presence of 100 U/ml IFN? (Strathmann Biotec, Hannover, 
Germany) in D10 medium. Cell lysates were prepared as previously described (2.1.3.2). Anti-
Flag? M2 Affinity Gel (Sigma-Aldrich, Munich, Germany) was washed twice in TBS 
(25 mM TrisHCl pH 7.2, 50 mM NaCl) before use according to manufacturers instructions. 
500 ?g total protein diluted in 1 ml Lysis Buffer (see 2.1.3.2) were mixed with 40 ?l Anti-
Flag? M2 Affinity Gel and shaked head over tail at 4°C for 2 h. Subsequently, the gel matrix 
was sedimented by centrifugation for 30 sec at 8000 xg and the supernatant was discarded. 
Than, the gel matrix was washed 3 times with 0,5 ml TBS. In the end the matrix was 
resuspended in 1x Laemmli Buffer (Laemmli, 1970) and incubated at 95°C for 2 min. 
Coimmunoprecipitation of ?1, ?2, ?1i and ?2i with ?5- or ?5i-Flag, respectively, was 
analysed by Two Colour Fluorescent Western Blot Analysis (see. 2.1.3.3). 
 
2.1.3.6 20S proteasome activity assay 
The proteolytic activity of 20S proteasomes was measured with fluorogenic peptide 
substrates. The chymotrypsin-like activity was routinely assayed with the substrate Suc-
LLVY-AMC (Biomol, Hamburg, Germany). 1 ?g purified 20S proteasomes or 10 ?l of 
fractions from the purification of 20S proteasomes (2.1.3.7) were added to 100 ?l reaction 
buffer (50 mM TrisHCl pH7.5, 10 mM NaCl, 30 mM KCl, 0,1 mM EDTA, 20 ?M Suc-
LLVY-AMC) and incubated at 37°C for 1 h in the dark. For the determination of background 
proteolytic activity each sample was measured in presence or absence of 10 ?M of the 
proteasome inhibitor MG132 (Sigma-Aldrich). Following incubation, the resulting 
fluorescence was detected with a Fluoroscan Ascent microplate reader (Thermo Labsystems, 
Waltham, MA, USA) at 355 nm excitation and 460 nm emission wavelength.  
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2.1.3.7 Purification of 20S proteasomes 
Organs were homogenized in Lysis Buffer (see 2.1.3.1) with a T8 basic Ultra-Turrax? (ISA? 
Maschinenbau, Staufen, Germany). The tissue homogenate was further broken up with a 
douncer and cleared by centrifugation at 17000 rpm for 30 min at 4°C. The organ lysates were 
mixed with DEAE Sephacel (GE Healthcare, Buckinghamshire, UK) eqilibrated in 2x TEAD 
(40 mM TrisHCl pH7.2, 2 mM EDTA, 2 mM NaN3, 2 mM DTT) and shaken head over tail 
for 1 h at 4°C. The loaded DEAE Sephacel was transferred to a column and washed with 10-
15 column volumes icecold 1x TEAD (20 mM TrisHCl pH7.2, 1 mM EDTA, 1 mM NaN3, 
1 mM DTT) supplemented with 50 mM NaCl until the flow through exhibited an absorbtion 
at A=280 nm below 0,08. This washing step was repeated with 1x TEAD, 150 mM NaCl. 
Subsequently, proteins were eluted with 1x TEAD, 350 mM NaCl and fractions with high 
chymotrypsin-like activity (2.1.3.6) were pooled. Then, a fractionated ammonium-sulfate 
precipitation was performed. First, ammonium sulfate was added to a final concentration of 
35% (w/v) under constant stirring on ice. The precipitated proteins were sedimented at 
25000 xg for 10 min at 4°C. The pellet was discarded and ammonium sulfate was added to the 
supernatant to a final concentration of 70% (w/v). Precipitated proteins were centrifuged at 
19000 xg for 20 min at 4°C. The supernatant was discarded; the pellet was solved in 600 ?l 
1x TEAD, 50 mM NaCl and cleared by centrifugation at 19000 xg for 10 min at 4°C. The 
clear supernatant was loaded on 10-40% sucrose gradients, which were centrifuged at 
2.8 x 10
5
 xg for 16 h at 4°C. The resulting fractions with highest chymotrypsin-like activity 
(2.1.3.6) were pooled and diluted 1 in 10 in Buffer A (1x TEAD, 100mM NaCl), filtered and 
subjected to FPLC. Proteins were loaded on a MonoQ HR 5/5 column (GE Healthcare) at a 
flow rate of 1 ml/min. The NaCl concentration during FPLC was increased stepwise at a flow 
rate of 1 ml/min with 5 min 0-20% Buffer B (1x TEAD, 1 M NaCl), 20 min 20-35% Buffer 
B, 2 min 35-100% Buffer B and 5 min 100% Buffer B. Fractions with high protein 
concentration according to absorption at A=280 nm and high chymotrypsin-like activity 
(2.1.3.6) were pooled. For further use, the buffer was exchanged against 1x TEAD, 50 mM 
NaCl and 20S proteasomes were concentrated on Amicon Ultra spin columns with 10 kDa 
cut-off (Millipore) according to manufacturers instructions. 
 
2.1.3.8 Digestion of peptide substrates with purified 20S proteasomes 
To determine proteasome-mediated processing of a LLO peptide substrate, 3 ?g of a synthetic 
27mer derived from the LLO sequence (LLO291–317: AYISSVAYGRQVYLKLSTNSHSTK 
VKA) were incubated at 37°C for 2–4 h with 1 ?g of purified 20S proteasomes (see 2.1.3.6) 
in 100 ?l of digestion buffer (HEPES/KOH pH 7.8, 2 mM magnesium-acetate, and 2 mM 
DTT). Reactions were stopped by adding trifluoroacetic acid to a final concentration of 0.1%. 
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2.1.3.9 Identification of proteasomal cleavage products 
Digestion products (see 2.1.3.7) were identified and quantified by liquid chromatography-
electrospray ionization-ion trap mass spectrometry (LC-ESI-MS) according to (Sijts, et al., 
2000). For statistical analysis, ion counts of each reaction were normalized to the internal 
standard 9GPS, a peptide (YPHFMPTNLGPS), which was added in equal amounts to each 
stopped reaction, and the mass of which does not interfere with the masses of any proteasomal 
cleavage product derived from LLO290–317. Two replicates were averaged.  
 
2.1.3.10 Measurement of cytokine secretion by BM-M? 
2 x 10
5
 BM-M? (see 2.1.2.3) per well of a 96well cell culture plate were seeded in D10 
medium and stimulated with 100 U/ml IFN? (Strathmann) over night at 37°C and 5% CO2. 
Next day, the medium was exchanged against 100 ?l/well D10 medium and cells were either 
left untreated or were infected with Listeria at a MOI of 1 for 1h at 37°C. Then, Gentamycin 
(Gibco) was added to a final concentration of 50 ?g/ml to kill extracellular bacteria. The cell 
culture supernatants were harvested at different time points, frozen in liquid nitrogen and 
stored at -20°C. The concentrations of IL-6 and TNF? in the supernatants were determined 
with the Bioplex Cytokine Bead Array System (Bio-rad) according to manufacturer`s 
instructions. The cytokine secretion was measured from three independent BM-M? 
preparations per group and time point.  
 
 
2.1.4 Molecular biological methods 
2.1.4.1 RNA isolation 
Organs were homogenized in TRIZOL? Reagent (Invitrogen) with a T8 basic Ultra Turrax. 
200 ?l Chloroform per ml TRIZOL? Reagent were added and samples were shaken for 30 sec; 
incubated for 5 min at room temperature and then centrifuged at 13000 rpm for 15 min at 4°C 
in a microfuge. Subsequently, the aqueous phase was transferred to a new reaction tube and 
500 ?l isopropanol, 120 ?l 5 M ammonium acetate and 10 ?l 0.5% (w/v) Glycogen were 
added per ml TRIZOL? Reagent. RNA was precipitated for 15 min at -20°C and sedimented 
by centrifugation at 13000 rpm for 15 min at 4°C in a microfuge. The supernatant was 
discarded and the pellet was washed with icecold 70% ethanol. The samples were centrifuged 
at 8000 rpm for 5 min at 4°C in a microfuge; the supernatants were discarded and the pellet 
was dried at the air. Then, the pellet was solved in deionized water and RNA concentration 
and quality were determined with a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, 
CA, USA). 
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2.1.4.2 cDNA synthesis 
2 ?g total RNA per sample were transcribed to cDNA with random hexamer primers and 
SuperScript? II Reverse Transcriptase (Invitrogen according) according to manufacturer´s 
instructions.  
 
2.1.4.3 Semi-quantitative Real-Time RT PCR  
Semi-quantitative Real-Time RT PCR reactions contained 1x SYBR Green mix (Applied 
Biosystems, Foster City, CA, USA), 10 pmol forward-primer, 10 pmol reverse-primer and 
5 ?l cDNA template (2.1.4.2) diluted 1:10 to 1:50 in UltraPure Water (Millipore) in a total 
volume of 30 ?l. The amplification was performed with an ABI Prism 7000 sequence 
detection system (Applied Biosystems) with the following programm: 2 min 50°C, 10 min 
95°C and 40 cycles with 15 sec 95°C and 15 sec 60°C. The runs were evaluated with the 
SDS2.2.2 Software (Applied Biosystems). Specificity of the products was assured by 
measurement of the products melting points. Amplification of PCR products derived from 
contaminating genomic DNA was excluded by the use of intron-exon spanning primer pairs 
(see 2.2.2). The expression of Ribosomal Protein Subunit 9 (RPS9) was used for 
standardization. The relative expression was calculated with the ??CT method. Relative 
expression values of proteasomal catalytic ?-subunits and POMP were determined from 3 
mice per group and time point.  
 
2.1.4.4 Molecular Cloning of vector constructs for retroviral transduction 
The vector pDest-Super used for retroviral transduction of MEFs (2.1.2.2) was provided by 
David Ermert (MPIIB). It is a hybrid plasmid, in which the MultiSite Gateway? Three 
Fragment recombination site from pDest?R4-R3 (Invitrogen) substitutes the cloning site of 
pSuper.retro.puro (OligoEngine, Seattle, WA, USA), which provides the flanking long 
terminal repeats (LTR) of MSCV and puromycin resistance. DNA-sequences encoding ?5 and 
?5i with C-terminal Flag-tag were amplified from a murine liver cDNA library (2.1.4.2) by 
nested PCR with Expand? High Fidelity Polymerase (Roche Applied Science). First, inserts 
were amplified using primer pairs ?5-start-for/?5-Flag-rev and lmp7-start-for/lmp7-Flag-rev 
(see 2.2.2) for ?5- and ?5i-Flag, respectively. The PCR products from the first reaction were 
used for further amplification with attB1- and attB2-adapter primers. Inserts with an IRES-
eGFP sequence were amplified from a plasmid provided by Marcus Koch (MPIIB) with 
primers IRES-eGFP-for/IRES-eGFP-rev (see 2.2.2). The inserts were purified by 
electrophoresis on a 1% Agarose Gel in 1x TAE (40 mM Tris-acetate pH8.5, 2 mM EDTA) 
and the QuiaQuick Gel Extration Kit (Quiagen, Düsseldorf, Germany) according to 
manufacturer’s instructions. Purified ?5- and ?5i-Flag inserts were subcloned into the entry 
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vector pDONR?221 (Invitrogen) and IRES-eGFP inserts into pDONR™P2R-P3 (Invitrogen) 
with the BP-recombination reaction according to the MultiSite Gateway® Three-Fragment 
Vector Construction Kit Manual. The pDONR™P4-P1R-EF-1? entry vector containing the 
sequence of the EF-1?-promoter was provided by David Ermert (MPIIB). Final expression 
vectors were generated by a LR-recombination reaction between pDest-Super, pDONR™P4-
P1R-EF-1?, pDONR?221-?5-Flag or pDONR?221-?5i-Flag and pDONR™P2R-P3-IRES-
eGFP according to manufacturer´s instructions resulting in the expression vectors pEX-EF-
1?-?5-Flag-IRES-eGFP and pEX-EF-1?-?5i-Flag-IRES-eGFP, respectively. One Shot? 
TOP10 chemically competent E. coli (Invitrogen) were transformed with the plasmids 
according to manufacturer’s instructions. Ampicillin resistant, Chloramphenicol sensitive 
clones were verified as positive clones by colony PCR with primers ?5-for/?5-rev and ?5i-
for/?5i-rev for pEX-EF-1?-?5-Flag-IRES-eGFP and pEX-EF-1?-?5i-Flag-IRES-eGFP, 
respectively. Verified clones were cultured and the plasmids were purified with the QuiaPrep 
Spin Miniprep Kit (Quiagen) according to manufacturer’s instructions. 
  
2.1.4.5 Preparation of retroviral particles 
The vector pEX-EF-1?-eGFP, which was provided by David Ermert (MPIIB) expressing 
eGFP from the EF-1? promoter, was used as empty vector control in the following 
experiments. Packaging of the expression vectors pEX-EF-1?-?5-Flag-IRES-eGFP, pEX-EF-
1?-?5i-Flag-IRES-eGFP and pEX-EF-1?-eGFP into ecotrophic retroviral particles was 
achieved by transient transfection of Phoenix E cells (2.1.2.1) by Ca-phosphate precipitation. 
2 x 10
6
 Phoenix E cells were seeded per cell culture dish with 10 cm-diameter. Next day, Ca-
phosphate-DNA precipitates were generated by mixing 20 ?g plasmid DNA (2.1.4.4) with 
32 ?l 2 M CaCl2 and 300 ?l 2x HBS Buffer (Clontech, Saint-Germain-en-Laye, France) 
adjusted to a final volume of 600 ?l with deionized water. The mixture was incubated for 
30 min at room temperature and the resulting precipitates were cautiously dispersed on the 
60-70% confluent monolayers of Phoenix E cells. 24 h later the medium was exchanged 
against fresh D10 medium. The supernatants containing retroviral particles were harvested 24 
and 48 h later, filtered through a sterile filter with 0,45 ?m pore-size and polybrene was added 
to a final concentration of 4 ?g/ml.  
 
2.1.4.6 Retroviral transduction of MEFs 
For retroviral transduction 2 x 10
4
 MEFs (2.1.2.2) were seeded per well of a 6well cell culture 
plate. 24 h later the medium was removed and 2 ml/well of the supernatants containing 
retroviral particles (2.1.4.5) were added to the MEFs. Plates were then centrifuged for 30 min 
at 2000 rpm and 30°C. The supernatants were removed 24 h later and the transduction was 
repeated with fresh supernatants. Another 24 h later the supernatants were exchanged against 
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D10 medium containing 10 ?g/ml Puromycin (Sigma-Aldrich) for selection of transduced 
MEFs. Following 2-4 weeks of culture under puromycin selection eGFP expressing cells were 
repeatedly sorted with a DIVA cell sorter (BD Biosciences) until a purity of >98% of eGFP 
high expressing MEFs was achieved.  
 
 
2.1.5 Flow cytometry 
2.1.5.1 Isolation of lymphocytes for flow cytometry 
Spleens were pressed through a metal wire with 120 ?m pore size. Splenocytes were 
resuspended in RPMI medium (RPMI 1640 (Gibco), 10% FCS, 1 mM L-glutamine, 1 mM 
sodium pyruvate, 100 U/ml penicillin, and 100 ?g/ml streptomycin) and sedimented by 
centrifugation at 1500 rpm for 5 min at 4°C.  
Liver lymphocytes were prepared by pressing livers through a metal wire with 120 ?m pore 
size. Then, cells were resupended in RPMI medium and centrifuged for 30 sec at 18 xg to 
remove hepatocytes and tissue debris. The pellet was discarded and the supernatant was again 
centrifuged at 18 xg for 30 sec. The lymphocytes in the supernatant were sedimented by 
centrifugation at 1500 rpm for 5 min at 4°C. 
Splenocytes and liver lymphocytes were resuspended in Erythrocyte Lysis Buffer (155 mM 
NH4Cl, 0,1 mM EDTA) and incubated for 3-4 min at room temperature. Lysis was stopped by 
adding 20 ml of RPMI medium. Following sedimentation at 1500 rpm for 5 min at 4°C the 
cells were resuspended in FACS buffer (1x PBS, 0.1% (w/v) BSA, 2 mM NaN3) for direct 
staining of cell surface markers (2.1.5.2) or in RPMI medium for ICS (2.1.5.3). 
 
2.1.5.2 Flow cytometric analysis of MHC class I surface expression 
First, 2 x 10
6
 splenocytes per sample were resuspended in 200 ?l FC-receptor block (1 ?g/ml 
CD16 and 1 ?g/ml CD32 antibodies (MPIIB) diluted in FACS buffer) and incubated for 
5 min at room temperature. Then, either CD11b-Pe-Cy7 (BD Pharmingen, Heidelberg, 
Germany), CD11c-Biotin (MPIIB), H2K
b
-Pe (BD Pharmingen), H2D
b
-Cy5 (MPIIB) and 
MHC class II-FITC (MPIIB) or CD11b-Pe-Cy7, CD11c-Biotin, MHC II-FITC and polyclonal 
hamster H2M3 antibodies were added to a final concentration of 2 ?g/ml each and cells were 
stained for 15 min at 4°C in the dark. Cells were washed with FACS Buffer, centrifuged at 
1500 rpm for 5 min at 4°C and supernatants were discarded. The cells were resuspended in 
200 ?l FACS Buffer containing 2 ?g/ml Streptavidin-APC-Cy7 (BD Pharmingen). Further, 
2 ?g/ml anti hamster IgG-Cy5 conjugated secondary antibodies (BD Pharmingen) were added 
to the stainings against H2M3. Cells were incubated for 15 min at 4°C in the dark. Cells were 
washed with FACS Buffer and resuspended in 0.5 ml FACS Buffer for flow cytrometric 
analysis on a FACS CANTO (BD Biosciences, Heidelberg, Germany). Data analysis was 
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performed with FCS express 3 (De Novo Software, Los Angeles, CA, USA). Briefly, 
CD11b
high
 MHCII
high
 and CD11c
high
 MHCII
high
 were regarded as M? or DCs, respectively. 
Relative surface density of MHC class I molecules on these cell types was determinded by 
mean fluorescence intensity (MFI) in the respective fluorescence channel. The MFI was 
measured on 3-4 splenocyte preparations per group and time point. 
 
2.1.5.3 Intracellular cytokine staining (ICS)  
Splenocytes and liver lymphocytes were cultured in RPMI medium. 5 x 10
5 
cells per well of a 
96well plate were incubated in the presence or absence of 1 ?g/ml LLO296–304 peptide 
(VAYGRQVYL). After 45 min of stimulation at 37°C and 5% CO2, brefeldin A (Sigma-
Aldrich) was added to a final concentration of 10 ?g/ml, and the cells were cultured for 
another 3–4 h. Following stimulation, cells were washed with 1x PBS and centrifuged for 
5 min at 1100 rpm. Cells were resuspended in 100 ?l FC-receptor block (1 ?g/ml CD16 and 
1 ?g/ml CD32 antibodies (MPIIB) diluted in FACS buffer) and incubated at room 
temperature for 5 min. Subsequently, CD8-PE-Cy7 (BD Pharmingen) and CD62L-PE 
(MPIIB) antibodies diluted in FACS buffer were added to a final concentration of 1 ?g/ml 
each and samples were incubated for 15 min at 4°C. Thereafter, cells were washed with 1x 
PBS and fixed in 4% (w/v) paraformaldehyde in 1x PBS for 20 min at room temperature. 
Fixation was stopped by washing with FACS buffer. Fixed cells were permeabilized for 5 min 
in saponin buffer (1x PBS, 0.5% (w/v) saponin (Sigma-Aldrich), 0.1% (w/v) BSA) before 
adding IFN?-FITC antibodies (MPIIB) to a final concentration of 2 ?g/ml. Following 
incubation for 15 min at 4°C, cells were washed with FACS buffer, and samples were 
measured on a FACS CANTO (BD Biosciences). The resulting data were analyzed using FCS 
Express 2 software (De Novo Software).  
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2.2 Materials 
2.2.1 Antibodies 
Antibodies used for Western Blot Analysis 
specificity host species clone used dilution supplier 
GAPDH mouse 6C5 1:2500 
Calbiochem, Darmstadt, 
Germany  
?1 rabbit polyclonal (K43) 1:5000 Institute for Biochemistry, 
Charité, Berlin, Germany 
?2 chicken polyclonal 1:5000 Abcam, Cambridge, UK 
?5 rabbit polyclonal 1:5000 Abcam, Cambridge, UK 
?1i rabbit polyclonal 1:5000 Abcam, Cambridge, UK 
?2i rabbit polyclonal 1:2500 Biomol, Exeter, UK 
?5i rabbit polyclonal (K63) 1:10000 Institute for Biochemistry, 
Charité, Berlin, Germany 
?3 mouse MCP257 1:5000 Calbiochem, Darmstadt, 
Germany 
POMP 
(HSPC014) 
chicken polyclonal 1:1000 Abcam, Cambridge, UK 
PA28? rabbit polyclonal 1:5000 Institute for Biochemistry, 
Charité, Berlin, Germany 
19S subunit S4 rabbit polyclonal 1:5000 
Institute for Biochemistry, 
Charité, Berlin, Germany 
20S proteasome  rabbit polyclonal (MP3) 1:5000 
Institute for Biochemistry, 
Charité, Berlin, Germany 
rabbit IgG- 
AlexaFluor680 
goat polyclonal 1:5000 
Molecular Probes, Eugene, 
OR, USA 
chicken IgY-
IrDye700 
goat polyclonal 1:5000 
Rockland, Gilbertsville, PA, 
USA 
mouse IgG-
IrDye800 
goat polyclonal 1:5000 
Rockland, Gilbertsville, PA, 
USA 
 
Antibodies used for Flow Cytometry 
specificity host species clone used dilution supplier 
CD11b-Pe-Cy7 rat M1/70 2 ?g/ml BD Biosciences, Heidelberg, 
Germany 
CD11c-Biotin mouse N418 2 ?g/ml MPIIB, Berlin, Germany 
H2K
b
-Pe mouse AF6-88.5 2 ?g/ml BD Biosciences, Heidelberg, 
Germany 
H2D
b
-Cy5 mouse HB27 2 ?g/ml MPIIB, Berlin, Germany 
H2M3 
armenian 
hamster 
clone130 2 ?g/ml BD Biosciences, Heidelberg, 
Germany 
MHC II mouse Tib120 2 ?g/ml MPIIB, Berlin, Germany 
hamster IgG-Cy5 mouse 
G70-204/ G94-
90.5 
2 ?g/ml BD Biosciences, Heidelberg, 
Germany 
CD8-Pe-Cy7 rat 53-6.7 2 ?g/ml BD Biosciences, Heidelberg, 
Germany 
CD62L-Pe rat Mel14 2 ?g/ml MPIIB, Berlin, Germany 
IFN?-FITC mouse XMG1.2 2 ?g/ml MPIIB, Berlin, Germany 
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2.2.2 Primer-sequences 
primer sequence (5’ to 3’)* 
?1-for TGACCAAGGACGAATGTCTG 
?1-rev GATTTGGTCTCCCAAAAGCA 
?2-for CTGTCTTGGAAGCGGATTTC 
?2-rev GCAACAACCATCCCTTCAGT 
?5-for GTGAATCAGCACGGGTTTT 
?5-rev AATCCGCTGCAACAATGACT 
?1i-for CATCATGGCAGTGGAGTTTGAC 
?1i-rev ACCTGAGAGGGCACAGAAGATG 
?2i-for CAGCCAAACATGACGCTGG 
?2i-rev CAGTGATCACACAGGCATCCAC 
?5i-for ACCACACTCGCCTTCAAGTTC 
?5i-rev GCCAAGCAGGTAAGGGTTAATC 
POMP-for AACATCCAGGGTCTGTTTGC 
POMP-rev TCGTTGCCCCTCAAAATATC 
RPS9-for CTGGACGAGGGCAAGATGAAGC 
RPS9-rev TGACGTTGGCGGATGAGCACA 
?5-start-for AAAAAGCAGGCTCCACCATGGCGCTGGCTAGCGTG 
?5-Flag-rev AGAAAGCTGGGTCTCAGATCTTATCGTCGTCATCCTTG- 
TAATCGGGGACAGATACACTAC 
lmp7-start-for AAAAAGCAGGCTCCACCATGGCGTTACTGGATCTGTG 
lmp7-Flag-rev 
AGAAAGCTGGGTCTCAGATCTTATCGTCGTCATCCTTG- 
TAATCCAGAGCGGCCTCTCCG 
attB1-for GGGGACAAGTTTGTACAAAAAAGCAGGCT 
attB2-rev GGGGACCACTTTGTACAAGAAAGCTGGGT 
IRES-eGFP-
for 
GGGGACAGCTTTCTTGTACAAAGTGGTCAGCTTCGAATTCTGCAGTCG 
IRES-eGFP-
rev 
GGGGACAACTTTGTATAATAAAGTTGCTTACTTGTACAGCTCGTCCATGC 
*All primers were obtained from TIB Molbiol, Berlin, Germany. 
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3 Results 
 
3.1 Analysis of 20S proteasome assembly in Listeria 
monocytogenes infected lmp7-/- mice 
 
According to the current model of cooperative proteasome assembly, ?1i and ?2i require ?5i 
for efficient maturation in i20S. This model is based on observations in T2 cells, which carry 
a deletion in the MHC class II locus covering the genes encoding for ?1i and ?5i. When these 
cells are reconstituted with ?1i but not ?5i, the maturation of ?1i and ?2i is almost aborted 
(Fig. II; Griffin et al., 1998).  
To analyse the impact of ?5i-deficiency on proteasome assembly in vivo, we infected lmp7-/- 
mice i.v. with Listeria. Due to the targeted deletion of the lmp7 gene, the  expression of ?1i 
and ?2i was expected to remain unaffected. In addition, this system allows the analysis of 
proteasome maturation in lymphoid or non-lymphoid tissues with either constitutive or IFN? 
induced immunosubunit expression, respectively.  
 
3.1.1 The abundance of catalytic ?-subunits in Listeria-infected 
WT and lmp7-/- mice  
 
The abundance of the proteasomal catalytic ??subunits in spleen and liver of C57Bl6/N (WT) 
and lmp7
-/-
 mice was analysed by Two-Colour Fluorescent Western Blot analysis following 
infection with Listeria (Fig.1; Fig.2). 
As expected, we observed a constitutive, high abundance of the immunosubunits in the spleen 
of naïve WT animals (Fig. 1A). Densitometric analysis revealed that the abundance of ?1i and 
?5i was unaffected by infection, while ?2i was about 2fold increased (Fig. 1B). The usage of 
the constitutive subunits ?1, ?2 and ?5 was generally low in the spleen of WT animals and 
was not influenced by infection (Fig. 1A-B).  
In the absence of ?5i in lmp7-/- mice, maturation of ?1i and ?2i was impaired as seen by 
accumulation of precursor proteins, pre-?1i and pre-?2i, respectively. Surprisingly, the 
majority of ?1i and ?2i subunits occurred as mature subunits, showing more efficient 
processing of these subunits in the absence of ?5i than expected (Fig. 1 A+B). 
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Figure 1. Protein abundance of catalytic ?-subunits in the spleen following infection with Listeria 
Spleens of naïve and infected WT and lmp7
-/-
 mice were isolated at the indicated time points post infection. Mice 
were infected i.v. with 5 x 10
3
 cfu of Listeria and organs were pooled from 3-4 mice per group. Organ lysates 
were separated by SDS-PAGE and subjected to Two-Colour Fluorescent Western Blot analysis. Each membrane 
was stained against GAPDH for standardization. Further, membranes were stained with antibodies specific for 
the six catalytic ?-subunits. Representative blots of 4 experiments are shown (A). Densitometric analysis was 
performed using the Odyssey Image Analyser software. Standardized band intensity was calculated as follows: 
(?-subunit signal / GAPDH-signal) x 100. The given results are means of two independent experiments, each 
analysed in duplicates (B). 
 
In contrast to WT spleen, the abundance of mature ?1i and ?2i subunits was approximately 
2fold increased following infection of lmp7
-/-
 mice indicating enhanced integration into 20S 
proteasomes.  
The usage of ?5 was 3-4fold increased in lmp7-/- mice as compared to WT mice, presumably 
to compensate the lack of ?5i. Interestingly, the constitutive, high abundance of ?5 in lmp7-/- 
spleen was not further increased following infection. The prevalence of ?1 and ?2 remained 
unaltered in lmp7
-/- 
mice during infection despite increased maturation of ?1i and ?2i. 
However, their abundance appeared 15-30% lower compared to WT mice at all time points 
analysed (Fig. 1B). 
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Figure 2. Protein abundance of catalytic ?-subunits in the liver following infection with Listeria 
Livers of naïve and infected WT and lmp7
-/-
 mice were isolated at the indicated time points post infection. Mice 
were infected i.v. with 5 x 10
3
 cfu of Listeria and organs were pooled from 3-4 mice per group. Organ lysates 
were separated by SDS-PAGE and subjected to Two-Colour Fluorescent Western Blot analysis. Each membrane 
was stained against GAPDH for standardization. Further, membranes were stained with antibodies specific for 
the six catalytic ?-subunits. Representative blots of 4 experiments are shown (A). Densitometric analysis was 
performed using the Odyssey Image Analyser software. Standardized band intensity was calculated as follows: 
(?-subunit signal / GAPDH-signal) x 100. The given results are means of two independent experiments, each 
analysed in duplicates (B). 
 
In the liver of naïve WT and lmp7
-/- 
mice, we observed high abundance of ?1, ?2 and ?5 (Fig. 
2A). In contrast, the abundance of ?1i and ?2i was low in naïve WT and lmp7-/- animals and 
revealed an 8-10fold increase upon infection. Interestingly, ?5i was readily detectable in 
naïve WT animals and its amount was only 2fold enhanced following infection, which 
revealed constitutive integration of this subunit in the liver (Fig. 2A-B). 
The abundance of ?1 and ?2 decreased with comparable kinetics in WT and lmp7-/- liver, 
indicating their replacement by ?1i and ?2i (Fig. 2B). Further, this demonstrates that 
competition between ?1 and ?2 with ?1i and ?2i occurs at similar rates in WT and lmp7-/- 
mice during proteasome assembly.  
Like in the spleen, maturation of ?1i and ?2i was impaired in the liver of lmp7-/- mice. The 
incidence of pre-?1i and pre-?2i in lmp7-/- mice peaked 2 days after infection and gradually 
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declined during the course of infection, while the abundance of mature subunits increased. 
Suprisingly, the ratio of pre-?1i and pre-?2i to mature ?1i and ?2i was much lower in the 
liver compared to the spleen (Fig 2 A-B). Eight days after infection less than 10% of total ?1i 
and ?2i were found as precursor subunits. This reveals that immunosubunits in lmp7-/- mice 
can efficiently pair with ?5 to form mixed proteasomes (m20S). However, the pool of m20S 
increases with slower kinetics as compared to i20S in WT mice. 
Further, we observed a replacement of ?5 in infected WT liver due to increasing ?5i levels 
(Fig. 2B). In contrast, in lmp7
-/-
 mice the abundance of ?5 remained constant during the 
course of infection (Fig. 2 A-B). This suggests that the usage of ?5 in lmp7-/- liver is already 
maximal and cannot be further enhanced to counterbalance ?5i-deficiency. Still, high 
constitutive expression of ?5 in the liver of lmp7-/- mice seems to allow more efficient 
integration of ?1i and ?2i as compared to the spleen. 
In summary, these findings show that ?5 can compensate for the lack of ?5i in lmp7-/- mice 
with unexpected efficiency, especially in the liver. Still, impaired maturation of ?1i and ?2i 
shows, that ?5 is a limiting factor for assembly of m20S in infection.  
 
3.1.2 Analysis of proteasome assembly in WT and lmp7-/- mice 
 
To verify that the maturation of ?1i and ?2i in lmp7-/- mice (Fig.1, Fig. 2) results in the 
formation of m20S in association with ?5, we employed 2D-Two-Colour Fluorescent Western 
Blot analysis. The combination of 2D gelelectrophoresis with the Two Colour Fluorescent 
Western Blot technology allowed us to analyse proteasome assembly without previous 
purification of the complexes. Membranes were stained for proteasome subunit ?3 as it is a 
component of assembly intermediates as well as mature proteasome complexes. Thus, ?3 
indicates the positions of the various complexes following their separation according to 
molecular weight in the first dimension. The positions of 13-16S precursor proteasomes, 20S 
proteasomes or 20S proteasomes bound to 11S and/or 19S regulatory complexes were 
confirmed by the presence of pre-?1i and staining for the 11S subunit PA28? or the 19S 
subunit S4, respectively (Fig. 3).  
Results  41 
 
Figure 3. Analysis of proteasome assembly by 2D Two Colour Fluorescent Western Blot Analysis 
Organ-lysates of spleen (A) and liver (B) of lmp7
-/-
 mice, which were infected i.v. with 5 x 10
3
 cfu of Listeria 4 
days before, were prepared in native lysis buffer and analysed by 2D Two Colour Fluorescent Western Blot 
analysis. First, protein complexes were separated by Blue Native-PAGE. In the second dimension single lanes of 
the Blue Native-PAGE were subjected to SDS-PAGE followed by Two Colour Fluorescent Western blot 
analysis. Each membrane was stained for ?3 (green signal). Besides the molecular weight difference of the 
complexes in the first dimension, ?3 is a marker for the presence and positions of 13-16S, 20S, 20S + 11S and 
26S complexes in the second dimension. The complexes were confirmed by staining against 19S ATPase subunit 
S4, 11S subunit PA28? or presence of pre-?1i-subunits (red signals). Arrows indicate the positions of the 
observed proteasome complexes. Organs of 3-4 mice per group were pooled for the analysis. 
 
In the spleen of naïve and infected WT mice, catalytic ?-subunits were exclusively detected in 
mature proteasome complexes, either as free 20S proteasomes or bound to 11S and/or 19S 
regulatory complexes (Fig. 4). Further, mature proteasome fractions in WT mice 
predominantly contained ?5i and only low amounts of ?5, which reflects the results of the 
densitometric analysis of conventional Western-Blots (Fig. 1B).  
Substantial amounts of ?1i and ?2i subunits in mature proteasomes were also detected in the 
spleens of naïve and infected lmp7
-/- 
mice (Fig. 4). This demonstrates that mature ?1i and ?2i 
subunits previously observed by conventional Western Blot analysis (Fig. 1A) are integrated 
into 20S proteasomes. In contrast to WT mice, we further detected high amounts of ?5 in 
mature proteasomes of lmp7
-/- 
mice, which confirms that ?5 can efficiently pair with ?1i and 
?2i to form m20S.  
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Figure 4. Analysis of proteasome assembly in the spleen following Listeria infection of WT and lmp7
-/-
 
mice  
Organ-lysates of the spleen were analysed by 2D Two Colour Fluorescent Western Blot analysis. First, protein 
complexes were separated by Blue Native-PAGE. In the second dimension single lanes of the Blue Native-
PAGE were subjected to SDS-PAGE followed by Two Colour Fluorescent Western blot analysis. Each 
membrane was stained for proteasome subunit ?3 (green signal). Besides the molecular weight difference of the 
complexes in the first dimension, ?3 is a marker for the positions of 13-16S, 20S, 20S + 11S and 26S complexes 
in the second dimension. Further, membranes were stained for the catalytic ?-subunits (red signals). This allows 
identifying, in which proteasome fractions the subunits are present in the spleen of naïve and infected WT (A) 
and lmp7
-/-
 mice (B). Arrows indicate the observed proteasome complexes. Mice were infected i.v. with 5 x 10
3
 
cfu Listeria and sacrified 4 days post infection. Organs of 3-4 mice per group were pooled for the analysis. 
 
In the livers of WT mice, catalytic ?-subunits were predominantly detected in mature 
proteasome fractions with increasing amounts of IFN? inducible subunits in infected 
compared to naïve mice. Only marginal amounts of pre-?1i were found in precursor 
proteasome complexes of WT mice (Fig.5). 
Also in the livers of lmp7
-/-
 mice, ?1i and ?2i incorporation into proteasome complexes was 
strongly enhanced upon infection. Interestingly, the majority of ?1i and ?2i subunits were 
detected in mature proteasome complexes, while only a small fraction was found in 13-16S 
assembly intermediates (Fig.5). This confirms that ?1i and ?2i are more efficiently integrated 
in the liver of lmp7
-/- 
mice as compared to spleen. 
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Figure 5. Analysis of proteasome assembly in the liver following Listeria infection of WT and lmp7
-/-
 mice  
Organ-lysates of the liver were analysed by 2D Two Colour Fluorescent Western Blot analysis. First, protein 
complexes were separated by Blue Native-PAGE. In the second dimension single lanes of the Blue Native-
PAGE were subjected to SDS-PAGE followed by Two Colour Fluorescent Western blot analysis. Each 
membrane was stained for proteasome subunit ?3 (green signal). Besides the molecular weight difference of the 
complexes in the first dimension, ?3 is a marker for the positions of 13-16S, 20S, 20S + 11S and 26S complexes 
in the second dimension. Further, membranes were stained for the catalytic ?-subunits (red signals). This allows 
identifying, in which proteasome fractions the subunits are present in the liver of naïve and infected WT (A) and 
lmp7
-/-
 mice (B). Arrows indicate the observed proteasome complexes. Mice were infected i.v. with 5 x 10
3
 cfu 
Listeria and sacrified 4 days post infection. Organs of 3-4 mice per group were pooled for the analysis.   
 
 
Still, the presence of pre-?1i and pre-?2i in precursor proteasomes of naïve and infected  
lmp7
-/-
 mice reveals impaired maturation of 20S proteasome complexes (Fig. 4 and 5). 
Because ?5 was predominantly found in mature proteasome complexes in lmp7-/- mice, but 
only traces were detectable in the accumulated 13-16S complexes, we suggest that integration 
of ?5 is a rate-limiting step for proteasome maturation in these mice. Thus, the neosynthesis 
of 20S proteasomes in the absence of ?5i seems to directly correlate with the availability of 
?5.  
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3.1.3 mRNA expression of the catalytic ?-subunits in WT and 
lmp7-/- mice 
 
We performed semi-quantitative Real-Time RT-PCR analysis to determine the impact of ?5i-
deficiency on the expression of the remaining catalytic ?-subunits following Listeria 
infection. 
The kinetics of ?1i and ?2i expression were comparable in WT and lmp7-/- mice in both 
analysed organs, demonstrating that ?5i-deficiency does not influence their expression (Fig. 6 
A-B). Also mRNA levels of ?1 and ?2 were similar in both groups of mice. Noteworthy, the 
expression of ?1 and ?2 remained constant following infection (Fig 6B), although their 
protein abundance declined in the liver (Fig. 2B), indicating that the down-regulation of 
constitutive subunits is not transcriptionally regulated. Instead, induction of IFN? inducible 
subunits results in the replacement of constitutive subunits at protein level, indicating 
competitive integration of catalytic ?- subunits during proteasome assembly.  
 
Figure 6. mRNA expression of the catalytic ?-subunits during Listeria infection  
Total RNA of spleen (A) and liver (B) of naïve and Listeria-infected WT and lmp7
-/-
 mice was isolated at the 
indicated time points and semi-quantitative Real Time RT PCR analysis was performed. The results were 
calculated as relative mRNA expression levels compared to the expression of the internal standard ribosomal 
protein subunit 9 (RPS9) by the ??CT method. Each value represents mean and standard error of three 
individual mice. The data shown are representative for two independent experiments. The values of ?1, ?2 and 
?5 are marked by filled squares in WT and open squares in lmp7-/- mice, respectively, while the values for ?1i, 
?2i and ?5i are indicated by filled circles for WT mice and open circles for lmp7-/- mice. 
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Interestingly, the mRNA expression of ?5 was not influenced by infection and no differences 
between WT or lmp7
-/-
 mice could be detected, neither in spleen nor liver (Figure 6A-B). The 
fact, that the mRNA expression of ?5 was not increased in lmp7-/- mice shows, that the 
deficiency of ?5i is not compensated at the transcriptional level.  
In contrast to similar ?5 mRNA levels, the protein abundance of ?5 in lmp7-/- mice was 
constitutively increased in the spleen and remained constant in infected liver, while it was 
decreased in WT mice (Fig.1; Fig.2). Further, despite increasing amounts of ?1i and ?2i 
proteins in infected lmp7
-/-
 mice, the abundance of ?5 was not further enhanced, suggesting 
that the usage of ?5 in lmp7-/- mice is maximal. In conclusion, the constant mRNA expression 
of ?5 seems to limit its availability during infection and is not sufficient to compensate ?5i-
deficiency. We thus speculate, that precursor proteasomes containing pre-?1i and pre-?2i 
cannot be completed due to shortage of free ?5 subunits and therefore accumulate in lmp7-/- 
mice.  
 
3.1.4 Quantification of 20S proteasomes in Listeria infected WT 
and lmp7-/- mice 
 
Our assumption that ?5 is a rate-limiting factor for proteasome assembly in lmp7-/- mice 
raised the question, if the cellular proteasome content might be reduced in these mice. Thus, 
we aimed to quantify the total amount of proteasome complexes in organ lysates of WT and 
lmp7
-/-
 mice during the course of infection. For this purpose, we employed the Two Colour 
Fluorescent Western Blot analysis with subsequent densitometry. 
For the detection of proteasomal subunits a polyclonal rabbit serum specific for murine 20S 
proteasomes was used. With this serum, termed MP3, multiple bands in a molecular weight 
range of 20-35 kDa according to the sizes of ?- or ?-type subunits were detected (Fig.7 A, B). 
One prominent band was identified as structural subunit ?3, as seen by complete overlay with 
the ?3 staining in 2D Two Colour Fluorescent Western Blot Analysis (Fig.7 E-F). It was not 
further characterized, which other subunits are detected by MP3. However, the band patterns 
observed by Western Blot analysis were identical in samples of WT and lmp7
-/-
 mice (Fig. 7 
A, B). 
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Figure 7. Quantitative analysis of the proteasome content during Listeria infection 
Organ lysates of naïve and infected spleen (A) and liver (B) of WT and lmp7
-/-
 mice were analysed by Two 
Colour Fluorescent Western Blot. The intensity of the proteasome subunit band pattern between 20-35 kDa (red 
signals) was quantified by densitometry and normalized to the band intensity of GAPDH (green signals). For the 
comparison of proteasome content between naïve and infected WT and lmp7
-/-
 mice, the normalized band 
intensity of naive WT mice was set to 100% (C, D). The densitometric analysis was performed in duplicates 
from two independent experiments. 3-4 mice per group and time point were infected i.v. with 5 x 10
3
 cfu of 
Listeria and 2D Two Colour Western Blot analysis of lmp7
-/-
 spleen (E) and liver  lysates (F) was performed to 
analyse, which proteasome complexes are stained by antibody MP3. The membranes were further stained for ?3 
as a marker for the occurring proteasome complexes, which are indicated by arrows.  
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This indicates, that differences in the overall band intensity do not simply rely on varying 
amounts of catalytic ?-subunits as previously shown (Fig1; Fig.2). Hence, it was concluded 
that MP3 predominantly stains structural subunits and that the quantification of the observed 
band pattern is a good correlate of the proteasomal content. 
For the comparison of proteasome amounts, the overall band intensity of the proteasome 
subunit pattern per lane was quantified and normalized to the internal standard GAPDH. The 
normalized band intensity of naïve WT mice was set to 100%. By this, it became obvious that 
in naïve spleens of lmp7
-/-
 mice the proteasome content was about 25% reduced (Fig.7 A, C), 
while in naïve liver of lmp7
-/-
 mice the proteasome content was decreased about 10% as 
compared to WT mice (Fig.7 B, D). This might be explained by the fact that ?5i is 
constitutively present in both organs of naive WT mice (Fig. 1 and 2).  
Interestingly, in both organs of WT mice, the proteasome content increased following 
infection. In striking contrast, the proteasome amount remained constant in infected lmp7
-/-
 
mice (Fig. 7 C, D). 
In spleens of WT mice, the proteasome amount was raised up to 20% after infection, which 
augmented the difference to lmp7
-/-
 mice up to 30-40% (Fig. 7B). In the liver of WT mice, the 
increase in proteasome content reached up to 30% with a maximal difference of 40% to   
lmp7
-/-
 mice (Fig. 7D). 
However, the antibody MP3 used for the quantification of proteasomes also stained subunits 
present in 13-16S precursor proteasomes of lmp7
-/-
 mice (Fig. 7 E, F). If these proteasome 
fractions could be excluded from the quantification, the difference in 20S proteasome content 
between WT and lmp7
-/-
 mice is expected to be even more pronounced. 
In summary, the results suggest that the concerted expression of all three immunosubunits is 
necessary to enhance the cellular proteasome content in infection. However, the constant 
amount of proteasomes in lmp7
-/-
 mice coincides with the observation that the abundance of 
?5 remained unchanged through the course of infection. In conclusion, these findings 
strengthen the hypothesis that impaired maturation of 20S proteasomes in lmp7
-/-
 mice is 
caused by the limited availability of ?5, which could be responsible for the reduced amount of 
catalytically active proteasomes per cell. 
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3.1.5 Analysis of POMP turnover in lmp7-/- mice 
 
Next, turnover of the proteasome maturation protein (POMP) was analysed. POMP is a 
chaperone that binds to precursor proteasomes and directly interacts with ?5 and ?5i (Fricke, 
et al., 2007; Heink, et al., 2005). It is a component of 13-16S precursor proteasomes and is 
necessary for the assembly of two 16S half proteasomes to a catalytically active 20S 
proteasome (Fig. I). Because it becomes the first substrate for newly formed 20S proteasomes 
(Ramos, et al., 1998), the degradation of POMP can be regarded as a marker for the rate of 
proteasome assembly.  
It was shown, that POMP mRNA expression is inducible by IFN? in vitro presumably to 
support the rapid neosynthesis of i20S. Further, expression of ?5i is sufficient to increase 
POMP turnover (Heink, et al., 2005). Thus, we wanted to analyse how ?5i-deficiency 
influences the expression of POMP and its turnover in infection. 
The analysis of POMP by Two Colour Fluorescent Western Blot revealed that it accumulates 
in naïve and infected spleens of lmp7
-/-
 mice and that its abundance is constitutively about 
5fold enhanced compared to WT mice (Fig. 8 A-B). In the liver of lmp7
-/-
 mice the abundance 
of POMP increased upon infection with Listeria. Its incidence peaked at day 2 after infection 
with a 4fold increase compared to WT mice and than gradually declined up to day 8. In 
contrast, POMP was barely detectable in spleens and livers of WT animals, indicating its 
rapid turnover in infection (Fig 8 C-D).  
However, POMP mRNA expression was comparable between WT and lmp7
-/-
 mice in spleen 
and liver (Fig. 8 E -F). Interestingly, in both organs the transcription of POMP was not 
significantly induced following infection. This was against our expectation, as POMP mRNA 
was shown to be inducible by IFN? in vitro and infection with Listeria results in systemic 
secretion of this cytokine (Strehl, et al., 2006). In addition, this shows that the accumulation 
of POMP in lmp7
-/-
 mice occurs at protein level. 
As degradation of POMP correlates with the neosynthesis of 20S proteasomes, the low levels 
of POMP coincide with the accelerated proteasome formation observed in infected WT mice. 
In contrast, the accumulation of POMP reflects the reduced neosynthesis of proteasomes in 
lmp7
-/-
 mice (Fig. 7). 
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Figure 8. POMP expression at protein and mRNA level following Listeria infection 
The abundance of POMP in organ lysates of naïve and infected spleen (A) and liver (C) of WT and lmp7
-/-
 mice 
was analysed by Two Colour Western Blot analysis. POMP was stained with a polyclonal antibody raised in 
chicken and anti chicken IgY IRDye700 labelled secondary antibodies. As a loading control membranes were 
further stained with mouse monoclonal anti-GAPDH antibodies and anti-mouse IgG IRDye800 labelled 
secondary antibodies. For densitometric analysis band intensities of POMP were normalized to the 
corresponding GAPDH signal. The quantification was performed in duplicates from two independent infections 
with 3-4 mice per group (B and D). mRNA expression of POMP in spleen (F) and liver (F) was measured by 
semi quantitative Real Time RT-PCR analysis. Expression levels of POMP were calculated as fold difference to 
the mRNA of the internal standard RPS9. Shown results are mean values ± standard error of 3 individual mice 
per time point. Given results are representative of two measurements from independent infections. Mice were 
infected i.v. with 5 x 10
3 
cfu of Listeria. 
 
The increased amounts of POMP in lmp7
-/-
 mice raised the question wether it is associated 
with precursor proteasome complexes or whether it is found as free protein. This question was 
addressed by 2D Two Colour Fluorescent Western Blot Analysis. We found that POMP is 
bound to the 13-16S precursor proteasome fractions of naïve and infected lmp7
-/-
 spleen as 
well as in infected lmp7
-/-
 liver, whereas free subunits could not be detected. As expected, 
POMP was not visible in proteasome complexes of WT spleen and liver (Fig. 9 A-B). 
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Figure 9: 2D-Two Colour Western Blot analysis of POMP in proteasome complexes 
The appearance of POMP in precursor proteasome complexes was analysed by 2D-Two Colour Western Blot. 
Organ lysates of naïve WT and lmp7
-/-
 spleen (A) and liver (B) as well as Listeria infected spleen and liver, 4 
days and 2 days post infection respectively, were separated by blue native PAGE. Single lanes were subjected to 
SDS PAGE in the second dimension and proteins were transferred to PVDF membrane. Membranes were 
stained with a polyclonal chicken antibody against POMP and IRDye700 conjugated secondary antibodies (red 
signals) as well as mouse monoclonal antibodies against ?3 and anti mouse IgG IRDy800 conjugated secondary 
antibodies (green signal). Arrows indicate the different proteasome complexes. Mice were infected with 5 x 10
3 
cfu of Listeria and organs were pooled of 3-4 mice per group. 
 
In conclusion, accumulation of POMP proteins in lmp7
-/-
 mice is caused by its stabilization in 
precursor proteasomes. Further, this demonstrates that POMP is a component of precursor 
proteasomes before ?5 or ?5i are integrated, as these subunits were absent in the observed 
precursor fractions (Fig. 4, 5). It is known, that ?5 or ?5i belong to the last subunits that are 
integrated in precursor proteasomes and that both subunits interact with POMP (Heink, et al., 
2005; Nandi, et al., 1997; Witt, et al., 2000). This confirms that the interaction of ?5 or ?5i 
with POMP is involved in their recruitment to precursor proteasomes as reported recently 
(Fricke, et al., 2007). Hence, accumulation of POMP in lmp7
-/-
 mice might be an indicator for 
a shortage of ?5 subunits that can be recruited to complete proteasome assembly. 
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Figure 10. Maturation of ?1i and ?2i in lmp7-/- MEFs overexpressing ?5 
Overexpression of a ?5-Flag fusion protein was achieved by retroviral transduction of lmp7-/- MEFs. The 
integration of ?1i and ?2i as well as the turnover of POMP was analysed in lmp7-/- MEFs overexpressing ?5-
Flag compared to lmp7
-/-
 MEFs transduced with empty vector or lmp7
+/+
 (WT) MEFs. Cell lines were either left 
untreated or stimulated with 50 U/ml IFN? for the indicated time periods. To determine the abundance of pre-?1i 
and pre-?2i subunits or mature ?1i and ?2i as well as POMP, protein lysates of these cells were subjected to 
Two Colour Fluorescent Western Blot analysis. Membranes were stained for ?1i (A), ?2i (B) and POMP (C) as 
well as GAPDH for standardization. The percentages of mature ?1i (D) or ?2i (E) were calculated as normalized 
band intensity of ?1i or ?2i devided through the total pre-?1i + ?1i or pre-?2i + ?2i signals multiplied with 100. 
To compare the degradation of POMP in the different cell lines, normalized band intensities measured following 
IFN? stimulation are shown (F). 
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3.1.6 Overexpression of ?5 in lmp7-/- MEFs 
 
According to our previous results, we wondered whether shortage of ?5 is responsible for 
impaired maturation of ?1i and ?2i in IFN? stimulated lmp7-/- cells. For this purpose, we 
generated retrovirally-transduced lmp7
-/-
 MEFs overexpressing a ?5-Flag fusion protein under 
control of the constitutive EF1? promoter (lmp7-/- MEFs + ?5-Flag). We achieved a 7,8fold 
increased expression of ?5 compared to lmp7-/- MEFs transduced with an empty vector 
construct (Table 1). Improved maturation of ?1i and ?2i under these conditions would support 
the assumption that the quantity of ?5 is a limiting factor following IFN? stimulation of   
lmp7
-/-
 cells.  
However, when we analysed the integration of ?1i and ?2i in lmp7-/- MEFs + ?5-Flag at 
various time points after IFN? stimulation, only a slight increase in mature ?1i subunits was 
detected as compared to empty vector controls. In average, the abundance of mature ?1i was 
10% increased and maximally 40% of total ?1i was integrated. This was still far beyond WT 
MEFs, in which more than 90% of total ?1i was found in its mature form (Fig. 10 A, D). 
Interestingly, the integration of ?2i could be enhanced up to 30% in lmp7-/- MEFs + ?5-Flag. 
Albeit with slow kinetics, up to 90% of total ?2i were integrated after IFN? stimulation, 
which is close to the maximal integration of WT MEFs (Fig.10 B, D). The strong integration 
of ?2i compared to ?1i is surprising, as it was reported that they mutually require each other 
for efficient maturation (Groettrup, et al., 1997). Further, this finding is in contrast to the 
efficient integration of both subunits in the liver of lmp7
-/-
 mice (Fig. 2B), but might be 
explained by the artificially high IFN? concentrations used for in vitro experiments.  
The degradation of POMP correlates with neosynthesis of 20S proteasomes (Heink, et al., 
2005; Ramos, et al., 1998). Compared to WT MEFs and lmp7
-/-
 MEFs transduced with an 
empty vector, we observed an intermediate degradation of POMP in lmp7
-/-
 MEFs + ?5-Flag. 
Taken together with the increased maturation of ?1i and ?2i, this finding underlines that the 
maturation of 20S proteasomes is improved by enhanced expression of ?5.  
In summary, overexpression of ?5 in lmp7-/- MEFs increases the integration of ?1i and ?2i. 
Still, the maturation of ?1i is drastically impaired and ?2i is integrated with much slower 
kinetics in lmp7
-/-
 MEFs + ?5-Flag as compared to WT MEFs. In conclusion, this suggests 
that it is not only the quantity that limits the integration of ?5. Instead, we assume that the 
slower rate of proteasome assembly that was reported in the presence of ?5 limits the 
maturation of m20S in lmp7
-/-
 mice, which might explain the accumulation of precursor 
proteasomes in these mice or IFN?-treated lmp7-/- MEFs (Heink, et al., 2005). 
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MEF cell line: 
?5 x 
expression 
?5i x 
expression 
WT MEFs + empty vector 1x 1x 
WT MEFs + ?5-Flag 33,2x 0,3x 
WT MEFs + ?5i-Flag 1,4x 3281x 
lmp7
-/-
 MEFs + empty vector 1x n.d. 
lmp7
-/-
 MEFs + ?5-Flag 7,8x n.d. 
 
Table 1: Expression levels of ?5 and ?5i in retrovirally transduced MEFs 
The mRNA expression of ?5 and ?5i in the retrovirally transduced MEF lines was analysed by Real-Time RT-
PCR. The expression of RPS9 was used for normalization. The fold-expression values of ?5 and ?5i were 
calculated by equating the corresponding empty vector controls to 1x expression. n.d.: not detectable 
 
 
3.1.7 Overexpression of ?5 in WT MEFs 
 
According? to the model of cooperative proteasome assembly, ?5i predominantly interacts 
with ?1i/?2i containing precursor proteasomes, while ?5 preferentially integrates into ?1/?2 
containing precursor proteasomes. However, our results so far suggest, that integration of ?5 
or ?5i is a competitive event, rather than a cooperative interaction of constitutive or 
immunosubunits.  
To follow up this question, we constructed retroviral vectors for constitutive overexpression 
of ?5 or ?5i fused to a C-terminal Flag-tag. The C-terminal fusion tag does not interfere with 
integration of the subunits and allows specific immunoprecipitation of proteasome complexes 
as has been shown previously (De, et al., 2003). This approach is employed to test whether ?5 
or ?5i specifically interact with constitutive or immunsubunits, respectively, or if their 
integration is competitive.  
The WT MEFs express ?1i and ?2i, but also endogenous ?5i exclusively following IFN? 
stimulation. This allows analysing whether the overexpressed ?5-Flag or ?5i-Flag proteins 
interact with ?1 and ?2 in unstimulated WT MEFs or with ?1i and ?2i in IFN? treated cells. 
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Figure 11. Coimmunoprecipitation analysis in ?5-Flag and ?5i-Flag overexpressing WT MEFs 
?5 or ?5i with a C-terminal Flag-tag fusion were stably overexpressed in WT MEFs by retroviral transduction. 
The expression of the Flag-tagged proteins as well as the endogenously expressed ?5 and ?5i subunits was 
analysed by Two Colour Fluorescent Western Blots in cell lysates of the indicated WT MEF cell lines. The cells 
were either left untreated or stimulated with 50 U/ml of IFN? for 4 days (A). The interaction of ?5-Flag and ?5i-
Flag with ?1/?2 or ?1i/?2i respectively was analysed by coimmunoprecipitation via the Flag-tag fusion (B).  
 
 
Although the expression of the ?5i-Flag construct was strongly increased compared to the 
basic expression level in empty vector controls (Table 1), the IFN? induced expression of 
endogenous ?5i was sufficient to compete with the overexpressed ?5i, as seen in the lysates 
before immunoprecipitation, in which native and Flag-tagged ?5i subunits were detectable 
(Fig. 11A).  
However, ?5i-Flag completely replaced the endogenous ?5 in unstimulated WT MEFs as seen 
by the absence of ?5 in the cell lysates before immunoprecipitation (Fig. 11A). Accordingly, 
we found that ?5i interacts with ?1 and ?2 in unstimulated WT MEFs. Overexpression of ?5i 
even allowed prolonged integration of ?1 and ?2 following IFN? stimulation. In contrast, ?1 
and ?2 were partly replaced in IFN? stimulated WT MEFs overexpressing ?5-Flag. As 
expected, ?1i and ?2i coimmunoprecipitated with ?5i-Flag in IFN? treated cells (Fig. 11B).  
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The expression of ?5 in WT-MEFs transduced with ?5-Flag was 33,2fold increased compared 
to empty vector controls. This expression was strong enough to oust the endogenous ?5, as 
predominantly ?5-Flag was detectable in the cell lysates (Fig. 11A). As expected, ?1 and ?2 
coimmunoprecipitated with ?5-Flag in unstimulated cells (Fig. 11B). However, ?1i and ?2i 
coimmunoprecipitated with ?5-Flag following IFN? stimulation of WT MEFs transduced with 
?5-Flag (Fig. 11B). This demonstrates that ?5 can compete with the induced expression of 
?5i when it is expressed at high levels. Still, the overexpressed ?5-Flag was partly replaced by 
the high expression of endogenous ?5i after IFN? stimulation, but to a lesser extent as 
compared to WT MEFs transduced with an empty vector construct (Fig. 11A). 
In summary, these data challenge the model of cooperative proteasome assembly suggested 
by Griffin et al., as no preferential integration of ?5i in ?1i/?2i- or of ?5 in ?1/?2-containing 
precursor proteasomes was detected (Griffin, et al., 1998; Kingsbury, et al., 2000). Thus, the 
results strongly support the hypothesis, that integration of ?5 and ?5i is predominantly 
regulated by competition at the protein level. However, in this process ?5i has two 
advantages, which facilitate the displacement of ?5 and rapid formation of i20S in lymphoid 
or infected tissue: First, its strong expression and second its accelerated recruitment by POMP 
as compared to ?5. 
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3.2 Functional impact of ?5i-deficiency on the immune 
response against Listeria monocytogenes 
 
A major aim of this study is the analysis of the immune response against Listeria in lmp7
-/- 
mice. As the structure of the 20S proteasome especially influences the peptide pools presented 
on MHC class I molecules, we focused on possible consequences for the CD8
+
 T cell 
response. For our analysis we chose the epitope LLO296-304 derived of Listeriolysin O, a major 
virulence factor of Listeria. It is the strongest antigenic determinant for CD8
+
 T cells in mice 
with the MHC class I haplotype H2
b
, such as C57Bl6 or 129Ola mice, which were used for 
this study. Still, the CD8
+
 T cell frequency directed towards this epitope is low (Geginat, et 
al., 2001). However, from our previous work we know that processing of LLO296-304 is 
drastically improved in the presence of i20S (Strehl, et al., 2006). Accordingly, processing of 
this epitope was expected to be decreased in lmp7
-/-
 mice and thus, we also anticipated a 
reduction in the frequency of LLO296-304 specific CD8
+
 T cells. In addition, we analysed the 
impact of ?5i-deficiency on bacterial control.  
 
3.2.1 Determination of MHC class I surface expression on 
professional APCs of lmp7-/- mice 
 
The phenotype of lmp7
-/- 
mice is characterized by a 25-50% reduction in MHC class I surface 
expression on a variety of immune cells, which underlines the importance of ?5i for efficient 
antigen processing and presentation (Fehling, et al., 1994). However, Fehling et al. did not 
determine the MHC class I surface expression on professional APCs following infection. 
Thus, we wanted to investigate whether the reduced MHC class I antigen presentation in 
lmp7
-/- 
mice is sustained on dendritic cells (DCs) or macrophages (M?) after Listeria 
infection.  
Presentation of antigens on professional APCs in lymphoid tissue within the first 2 days of 
Listeria infection is essential to elicit a CD8
+
 T cell response (Mercado, et al., 2000; Wong 
and Pamer, 2003). Thereafter, proliferation of CD8
+
 T cells is mostly antigen independent 
(Wong and Pamer, 2001). Therefore, the MHC class I surface density on professional APC 
subsets of the spleen was determined in WT and lmp7
-/- 
mice before and 2 days after infection. 
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Figure 12. MHC class I surface expression on professional APCs of Listeria infected WT and lmp7
-/-
 mice 
Surface expression of MHC class I molecules H2K
b
 and H2D
b
 as well as MHC class Ib molecule H2-M3 was 
measured on APCs by flow cytometry. Splenocytes were prepared of naïve lmp7
-/-
 and WT mice or 2 days after 
i.v. infection with 5 x 10
3
 cfu of Listeria. For differentiation of APC subtypes, cells were stained with antibodies 
for surface markers CD11b, CD11c and MHC class II. Mature, activated dendritic cells (A) or Macrophages (B) 
were identified as CD11c
high
 MHC class II
high
 expressing and CD11b
high
 MHC class II
high
 expressing cells, 
respectively. The surface expression of H2K
b
, H2D
b
 and H2-M3 on the APC populations was determined by 
measurement of the median fluorescence intensity (MFI) of the respective stainings. Shown are representative 
histograms of naïve WT and lmp7
-/-
 mice indicated by green doted and red doted lines, respectively as well as 
APCs of Listeria-infected WT and lmp7
-/-
 mice are indicated by green solid and red solid lines, respectively. The 
given values of MFI are mean values ± standard deviation of 3-4 mice per group. 
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As lineage markers for professional APCs, splenocytes were stained with antibodies against 
CD11c for DCs and CD11b for M?. As these markers are also expressed on other cell types, 
we selected CD11c and CD11b high expressing cells during FACS analysis, which represent 
predominantly DCs and M?, respectively. Further, the cells were stained for MHC class II, as 
upregulation of this molecule can be used as an activation marker for APCs. Accordingly, the 
analysis of MHC class I surface expression was focused on CD11c
high
 MHC class II
high
 and 
CD11b
high
 MHC class II
high
 expressing cells, which represent mature and activated DCs and 
M?, respectively. Although our model epitope LLO296-304 is presented via H2Kb, we were 
interested in the overall impact of ?5i-deficiency on MHC class I antigen presentation and 
also measured the surface expression of H2D
b
 and the non-classical MHC class Ib molecule 
H2M3.  
To quantify the reduction of MHC class I surface expression on APCs of lmp7
-/-
 mice, the 
surface expression of the corresponding APC population in WT mice was set to 100% (Fig. 
12). By this calculation we found, that the surface expression of H2K
b
 and H2D
b
 on DCs of 
naïve lmp7
-/-
 mice is decreased about 36% and 30%, respectively. This reduction in MHC 
class I molecules on DCs of lmp7
-/-
 mice remained unaltered after Listeria infection, as the 
average surface expression of H2K
b
 was 39% and that of H2D
b
 31% lower as compared to 
WT DCs (Fig. 12A).  
Similar results were found for M? of naïve and Listeria infected lmp7-/- mice. The H2Kb 
surface expression on M? of naïve lmp7-/- mice was about 23% and the H2Db surface 
expression 34% reduced. Accordingly, the average surface density of H2K
b
 was 40% and that 
of H2D
b
 35% decreased on M? of Listeria infected lmp7-/- mice (Fig. 12B). 
In summary, these data confirm that MHC class I antigen presentation is reduced on 
professional APCs of lmp7
-/-
 mice, which is maintained during Listeria infection. In addition, 
these findings underline the importance of ?5i for efficient antigen processing by professional 
APCs. As the difference in MHC class I surface expression was found within the first two 
days of infection, which are critical for CD8
+
 T cell priming, it is assumed that the LLO296-304 
specific CD8
+
 T cell response might be impaired in lmp7
-/-
 mice. 
Besides presentation of antigens on classical MHC class I molecules, n-formyl methionine 
containing peptides are presented on non-classical MHC class Ib molecules in bacterial 
infections. MHC class Ib restricted CD8
+
 T cells, expand more rapidly compared to classical 
MHC class I restricted CD8
+
 T cells. This early arm of adaptive immunity is important for the 
control of Listeria 3-7 days after infection (Kerksiek, et al., 1999; Seaman, et al., 2000). The 
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three dominant n-formyl methionine containing peptides of Listeria are directly secreted into 
the host cell cytosol and are presented on MHC class Ib molecule H2-M3 without further 
processing (Pamer, 2004). Thus, it was not expected, that their presentation would be affected 
in lmp7
-/-
 mice. Accordingly, when H2-M3 surface expression was determined on DCs (Fig. 
12A) and M? (Fig. 12B) no differences between WT and lmp7-/- mice were detected. This 
confirms, that presentation of peptides on MHC class Ib molecules is not influenced by ?5i-
deficiency. Further, this suggests that the function of MHC class Ib restricted CD8
+
 T cells as 
an effector mechanism of early adaptive immunity against Listeria is not impaired in lmp7
-/-
 
mice. 
 
3.2.2 Analysis of LLO296-304 epitope generation by 20S 
proteasomes isolated from lmp7-/- mice 
 
Recently, we could show that efficient generation of the LLO296-304 epitope correlates with the 
presence of i20S in lymphoid and infected tissues (Strehl, et al., 2006). According to the 
model of cooperative proteasome assembly, we anticipated that ?1i and ?2i would be barely 
integrated in 20S proteasomes of lmp7
-/-
 mice, which would consequently result in complete 
absence of immunosubunits (Griffin, et al., 1998). Thus, we expected impaired processing of 
LLO296-304 in lmp7
-/-
 mice. However, the data presented so far, revealed efficient integration of 
?1i and ?2i in lmp7-/- mice leading to the formation of m20S. This raised the question, if 
processing of LLO296-304 requires the specific activity of i20S or if the integration of ?1i and 
?2i in m20S is sufficient for efficient processing of LLO296-304. 
To address this question, 20S proteasomes were isolated from naïve and infected spleen and 
liver of WT and lmp7
-/-
 mice and incubated with a 27mer peptide substrate encompassing the 
LLO296-304 epitope (LLO substrate; Fig. 13A). The cleavage products generated from the LLO 
substrate were analysed by LC-ESI mass spectrometry. The digestion products detected by 
mass spectrometry are shown in Fig. 13A. The sequence of the LLO296-304 epitope and its 
precursor LLO294-304 are depicted in black. The generation of both, epitope and precursor, was 
quantified (Fig.13 B-C), because the precursor carries the correct C-terminus of LLO296-304 
and can be trimmed to the correct epitope by post-proteasomal processing. Thus, the precursor 
epitopes may contribute to the pool of peptides presented by H2K
b
 molecules.  
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Figure 13. Analysis of LLO296-304 epitope generation by isolated 20S proteasomes from WT and lmp7
-/-
 
mice  
20S proteasomes were isolated of naïve or infected spleen and liver of 5 WT and lmp7
-/-
 mice per group. Mice 
were infected i.v. with 5 x 10
3
 cfu of Listeria 4 days prior to isolation of 20S proteasomes. The utilized 27mer 
peptide substrate is derived from the Listeriolysin O sequence and encompasses the LLO296-304 epitope (LLO 
substrate). The LLO substrate was incubated with the different proteasome preparations for 4 h at 37°C. The 
cleavage products resulting from processing of the LLO substrate were quantified by LC-ESI-mass spectrometry 
as relative intensities compared to the signal of the standard peptide 9GPS that was added to all reactions in the 
same concentration. Among the occurring cleavage products the LLO296-304 epitope (?) and its precursor 
LLO294-304 (??) are depicted in black (A). The generation of epitope and precursor by 20S proteasomes from 
spleen (B) and liver (C) was quantified in duplicates. 
 
The quantification revealed that processing of the LLO substrate by 20S proteasomes isolated 
from the spleens of WT mice was more efficient as compared to those isolated from lmp7
-/-
 
mice. Further, processing of the LLO substrate was not significantly enhanced by 20S 
proteasomes isolated from spleens of infected WT mice, which can be explained by the 
constitutively high abundance of i20S in WT spleen (Fig. 13B). However, compared to WT 
mice, proteasome mediated generation of LLO296-304 and LLO294-304 was about 50% reduced 
by 20S proteasomes isolated from spleens of naïve or infected lmp7
-/-
 mice (Fig 13 B).  
20S proteasomes isolated from the livers of naïve WT and lmp7
-/-
 mice were inefficient in 
processing the LLO substrate. This was expected, since naïve livers predominantly contain 
c20S. However, 20S proteasomes isolated from the liver of infected WT mice revealed 4fold 
increased LLO296-304 epitope processing and 5fold elevated generation of the precursor epitope 
LLO294-304. In contrast, 20S proteasomes prepared from the liver of infected lmp7
-/-
 mice did 
not show increased processing of the LLO substrate. In conclusion, enhanced LLO296-304 and 
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LLO294-304 generation coincides with the induction of i20S in the liver of WT mice, but not 
with the formation of m20S in lmp7
-/-
 mice. 
Although substantial amounts of ?1i and ?2i were integrated in m20S of infected lmp7-/- mice 
(Fig. 1-4), processing of the LLO substrate was diminished compared to WT mice. In 
conclusion, this demonstrates that the activity of m20S cannot compensate the activity of i20S 
in LLO processing. Still, it cannot be clarified, if generation of LLO296-304 or LLO294-304 
depends on the specific activity of ?5i or if it requires the unique, structural features of i20S. 
 
3.2.3 Quantification of LLO296-304 specific CD8
+ T cells in WT and 
lmp7-/- mice  
 
So far, reduced cell surface expression of MHC class I molecules on professional APCs and 
decreased generation of the epitope LLO296-304 was detected in lmp7
-/-
 mice infected with 
Listeria. To test whether the CD8
+
 T cell response directed against LLO296-304 is affected by 
the limited antigen presentation in lmp7
-/-
 mice, we analysed priming and expansion of 
LLO296-304 specific CD8
+
 T cells by intracellular cytokine staining (ICS) in WT and lmp7
-/-
 
mice (Fig. 14). 
Following stimulation with the LLO296-304 peptide, IFN? producing CD8+ T cells were 
detected in lymphocyte preparations of spleen (Fig. 14A) and liver (Fig. 14B) in both groups 
of mice. In contrast, only background staining for IFN? was recognized in unstimulated 
controls in all lymphocyte preparations tested (Fig. 14 A-B). This demonstrates that     
LLO296-304 specific CD8
+
 T cells could be specifically detected by ICS in WT and lmp7
-/-
 mice 
infected with Listeria. 
Further, we used CD62L expression as an activation marker; with CD62L
low
 expressing cells 
representing recently activated CD8
+
 effector T cells. Accordinly, LLO296-304 specific CD8
+
 T 
cell frequencies are expressed as the percentage of IFN?+ cells among CD62Llow CD8+ T cells 
(Fig. 14 C-D).  
However, no significant differences in the frequencies of LLO296-304 specific effector CD8
+
 T 
cells were detected in WT and lmp7
-/-
 spleen at any analysed time point after infection. In 
both groups of mice, the CD8
+
 T cell frequencies peaked 10 days post infection with an 
average of 0.35% in WT and 0.25% in lmp7
-/-
 mice (Fig. 14C). 
Similar results were obtained for the liver, as comparable frequencies of LLO296-304 specific 
CD8
+
 T cells were found in WT and lmp7
-/-
 mice (Fig. 14D). Like in the spleen, CD8
+
 T cell 
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frequencies were maximal 10 days post infection with an average of 0.45% in WT and 0.50% 
in lmp7
-/-
 mice. 
In conclusion, this demonstrates that impaired processing of LLO296-304
 
and reduced MHC 
class I antigen presentation on professional APCs of lmp7
-/-
 mice is not limiting for priming 
and expansion of LLO296-304
 
specific CD8
+
 effector T cells. 
 
 
 
Figure 14. LLO296-304 specific CD8
+
 T cells in WT and lmp7
-/-
 mice following infection with Listeria 
Lymphocytes of spleen and liver of WT and lmp7
-/-
 mice were isolated at indicated time points after i.v. infection 
with 10
3
 cfu Listeria. Lymphocytes were either left untreated or stimulated with 1 ?g/ml LLO296-304 peptide in 
the presence of brefeldin A. Following stimulation, cells were subjected to intracellular cytokine staining. Shown 
are representative FACS dot plots of CD8 vs. IFN? stainings with lymphocytes of spleen (A) and liver (B) 
isolated 10 days after infection with Listeria. Frequencies of LLO296-304 specific CD8
+
 T cells in spleen (C) and 
liver (D) are shown as % IFN?+ cells of CD8+ CD62Llow cells following peptide stimulation (LLO) of 
lymphocytes isolated of WT (black bars) or lmp7
-/-
 mice (open bars) at the indicated time points post infection. 
Background staining is shown as % IFN?+ cells of CD8+ CD62Llow cells in unstimulated (medium) controls. 
LLO296-304 specific CD8
+
 T cell frequencies were measured in 3 individual mice per group. Shown are 
representative results of two independent experiments. 
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3.2.4 Analysis of bacterial control in Listeria infected WT and 
lmp7-/- mice 
 
Although we did not detect any significant differences in CD8
+
 T cell responses directed 
against our model epitope LLO296-304, we were interested whether the control of Listeria 
infection is affected by ?5i-deficiency. Thus, bacterial titers were determined in spleen and 
liver of WT and lmp7
-/-
 mice during the time course of infection.  
In the first 2 days after infection bacterial burdens were comparable in spleen and liver of WT 
and lmp7
-/-
 mice showing that early bacterial control was not affected. Unexpectedly, bacterial 
titers in spleen and liver were significantly increased 3-4 days post infection in lmp7
-/-
 
compared to WT mice. The median baterial burden was 10fold increased in the spleens and 
15fold enhanced in the livers of lmp7
-/-
 mice. This defect is independent of MHC class I 
restricted CD8
+
 T cell function, because in primary infection CD8
+
 effector T cells do not 
mediate significant protection before day 5 after infection. As predominantly innate immune 
defence mechanisms mediate control of Listeria infection at that time, these results suggest a 
so far unreported role of ?5i in innate immunity.  
 
 
 
Figure 15. Analysis of bacterial titers in WT and lmp7
-/-
 mice during the Listeria infection 
WT and lmp7
-/-
 mice were infected i.v. with 5 x 10
3
 cfu of Listeria and sacrificed at the indicated time points post 
infection. Organs were homogenized in 1x PBS and serial dilutions were plated on Palcam agar plates. Bacterial 
titers of spleen (A) and liver (B) were determined in 3-4 individual mice per group and time point from 3 
independent experiments. For each group the median is indicated and significance was determined by the Mann-
Whitney non-parametric t-test. Significance levels: * p<0,05; ** p<0.01; *** p<0,001. 
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Bacterial titers in spleens of lmp7
-/-
 mice adjusted to the level of WT mice 8 days after 
infection and the Listeria were cleared with similar kinetics until day 12 post infection (Fig. 
15A). This finding indicates, that in the spleen reduced MHC class I surface expression is not 
limiting for CD8
+
 T cell mediated clearance of Listeria.  
However, compared to WT mice clearance of Listeria from the livers of lmp7
-/-
 mice was 
delayed. While the bacteria were largely eliminated in WT mice 8 days after infection, the 
median bacterial burden in lmp7
-/-
 mice was still above 10
2 
cfu. The Listeria were cleared 
from the livers of lmp7
-/-
 mice 10 days after infection, showing that irradication of the bacteria 
was two days delayed in these mice (Fig. 15B).  
Because late control of Listeria depends on adaptive immunity (Ladel, et al., 1994), these 
results suggest an impaired function of the CD8
+
 T cell response in liver but not spleen of 
lmp7
-/-
 mice. This was surprising, as reduced MHC class I antigen presentation did not affect 
CD8
+
 T cell frequencies neither in spleen nor liver of lmp7
-/-
 mice (Fig. 14). Thus, we assume 
that reduced MHC class I surface expression on infected target cells of lmp7
-/-
 mice limits 
their recognition by CD8
+
 T cells and is consequently responsible for delayed bacterial 
clearance. As the control of Listeria was only impaired in the liver, we propose that the 
reduced MHC class I antigen presentation in lmp7
-/-
 mice is especially limiting for recognition 
of non-lymphoid target cells like hepatocytes.  
 
3.2.5 Proinflammatory cytokine secretion by Listeria-infected 
lmp7-/- macrophages in vitro 
 
The analysis of listerial titers revealed an impaired control of the bacteria in spleen and liver 
of lmp7
-/-
 mice 3-4 days post infection (Fig. 15). At that time, anti-bacterial immunity depends 
on innate immune defence mechanisms. This raised the question, how ?5i-deficiency may 
influence early bacterial control. 
M? represent a major arm of innate immunity in bacterial infection. Thus, we investigated 
wether M? function might be affected in lmp7-/- mice. For this reason, bone marrow derived 
macrophages (BM-M?) were generated from WT and lmp7-/- mice and infected with Listeria 
in vitro. The secretion of the proinflammatory cytokines IL-6 and TNF? was measured as an 
indication for the activation of BM-M? following infection. 
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While the IL-6 production by WT BM-M? was maximal 12 h post infection, the secretion of 
IL-6 by lmp7
-/-
 BM-M? was induced with slower kinetics (Fig. 16B). Further, TNF? release 
by lmp7
-/-
 BM-M? was reduced compared to WT BM-M?; most pronounced 6 h after 
infection (Fig. 16A). These results indicate impaired secretion of proinflammatory cytokines 
by M? of lmp7-/- mice and suggest that ?5i-deficiency has a so far unreported role in innate 
immune defence mechanisms. 
 
 
 
 
 
Figure 16. Secretion of proinflammatory cytokines by WT and lmp7
-/-
 BM-M?  infected with Listeria 
Bone marrow derived macrophages (BM-M?) were generated of WT and lmp7-/- mice. 2 x 105 BM-M? per well 
were seeded in 96well plates and stimulated over night with 200 U/ml IFN? for activation. Next day BM-M? 
were infected with Listeria at a MOI =1 and cell culture supernatants were harvested at the indicated time points. 
Concentrations of proinflammatory cytokines IL-6 and TNF? in the supernatants were measured with the 
Bioplex cytokine bead array system (Biorad). Secretion of cytokines was measured in three independent 
preparations of WT and lmp7
-/-
 BM-M?. 
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4 Discussion 
4.1 The structural impact of ?5i-deficiency on 20S proteasome 
assembly 
 
The role of ?5i in proteasome assembly was previously investigated in T2 cells reconstituted 
with lmp2 or lmp2 and lmp7 in vitro. In this system, expression of ?5i is essential for efficient 
integration of ?1i and ?2i in 20S proteasomes, which suggested that immunosubunits form 
i20S by cooperative assembly (Griffin, et al., 1998).  
Here, we determined the impact of ?5i-deficiency on integration of ?1i and ?2i in different 
organs of Listeria-infected lmp7
-/-
 mice. Our results challenge the current model of 
cooperative assembly, because we found efficient integration of ?1i and ?2i in m20S in 
association with ?5. In the following, the relevance of our findings with regard to the current 
opinion is discussed. 
 
4.1.1 Formation of m20S in lmp7-/- mice 
 
According to the concept of cooperative proteasome assembly, ?5i predominantly interacts 
with ?1i and ?2i containing precursor proteasomes to form i20S, while ?5 is restricted to ?1 
and ?2 containing precursor proteasomes resulting in c20S (Griffin, et al., 1998). Further, it is 
claimed that the ?5i-prosequence mediates specific interaction with pre-?1i and pre-?2i 
(Kingsbury, et al., 2000). However, the ability of the ?5i-propeptide to interact with ?1 and 
?2 and the influence of subunit quantities was not shown by Kingsbury et al., although it was 
already suggested that ?5i can also pair with ?1 and ?2. By now, various subtypes of 
proteasomes with mixtures of constitutive and immunosubunits have been identified. 
However, formation of m20S with ?1i/?2i/?5 stoichiometry is still regarded as highly 
inefficient (De, et al., 2003; Kingsbury, et al., 2000; Klare, et al., 2007). In contrast, 
integration of ?1i and ?2i in 20S proteasomes of lmp7-/- splenocytes has been reported 
previously (Stohwasser, et al., 1996). However, the maturation of ?1i and ?2i subunits with 
correlation to their precursors was not quantified in this study. 
Here, we found that especially in the liver of infected lmp7
-/-
 mice up to 90% of ?1i and ?2i 
subunits were found in their mature form. Further, compared to WT mice, ?1 and ?2 were 
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replaced with similar kinetics in the liver of lmp7
-/-
 mice, which demonstrates that ?5 
predominantly interacts with ?1i and ?2i following infection. In addition, we found that ?5-
Flag protein overexpressed in WT MEFs can also pair with ?1i and ?2i in competition with 
IFN??induced ?5i. Altogether, this demonstrates efficient formation of m20S with ?1i/?2i/?5 
stoichiometry. 
Also when we analysed the interaction of ?5i with other catalytic ?-subunits, we did not 
detect a preferential interaction with immunosubunits. Instead, constitutive overexpression of 
?5i leads to the formation of 20S proteasomes with ?1/?2/?5i stoichiometry. Further, we 
detected high levels of mature ?5i in naïve livers of WT mice, while ?1i and ?2i were barely 
detectable, which suggests interaction with ?1 and ?2 also in vivo.  
Thus, our data challenge the concept of preferential interaction of ?5i with ?1i and ?2i 
containing precursur proteasomes and the ?5i propeptide seems to generally facilitate the 
integration of this subunit in 20S proteasomes. This is in agreement with other reports that 
revealed efficient integration of ?5i in lmp2-/- and mecl1-/- mice or formation of various 
proteasome subtypes with various combinations of ?5i with constitutive or immunosubunits 
(Basler, et al., 2006; Groettrup, et al., 2001; Klare, et al., 2007). 
Instead, our results suggest that integration of ?5 or ?5i is substantially regulated by 
competition at the protein level. Thus, we propose that simultaneous overexpression of all 
three immunosubunits in lymphoid or infected tissues is an important mechanism of i20S 
formation. 
However, at mRNA level simultaneous overexpression of all three immunosubunits was only 
found in infected liver. In the spleen, where i20S are the prevalent proteasome type, 
(Kuckelkorn, et al., 2002), only ?1i revealed constitutively higher mRNA expression 
compared to ?1, while ?2i and ?5i reached the expression levels of ?2 and ?5 only after 
infection. However, Groettrup et al. showed that ?1i and ?2i mutually improve their 
integration into i20S (Groettrup, et al., 1997). Hence, high expression of ?1i in naive spleens 
might be sufficient to promote integration of ?2i. 
In contrast, we observed increased integration of ?2i independently of ?1i in spleens of 
infected WT mice. In addition, overexpression of ?5 in lmp7-/- MEFs substantially improved 
the integration of ?2i while that of ?1i was only marginally enhanced. These findings indicate 
that besides mutual interaction, the integration of ?2i is also influenced by competition with 
?2 at protein level.  
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Gaczynska et al. demonstrated that overexpression of ?1 downregulates the integration of ?1i 
and vice versa, which fits to our model of competitive integration (Gaczynska, et al., 1996). 
However, this study also reported that overexpression of ?5 downregulates the percentage of 
integrated ?1i, which was interpreted as preferential interaction of ?5 with ?1. But it was 
shown, that overexpression of ?5 increases the total proteasome content per cell 
(Chondrogianni, et al., 2005; Liu, et al., 2007). Increasing the amount of proteasomes might 
reduce the competition of ?1 and ?1i and could allow parallel integration of both subunits, 
which would consequently decrease the ratio of ?1i to ?1. Accordingly, we found improved 
integration of ?1i and ?2i in IFN?-stimulated lmp7-/- MEFs overexpressing ?5 and parallel 
integration of ?1 and ?1i in IFN?-stimulated WT MEFs overexpressing ?5i. Thus, the results 
of Gaczynska et al. can also be explained by our concept of competitive integration of 
catalytic ?-subunits (Fig. III).  
On the basis of our data we cannot exclude that higher affinity of immunosubunits to 
assembling proteasome complexes contributes to the formation of i20S. In agreement with 
this, ?1i is found in earlier assembly intermediates compared to ?1 indicating its preferential 
integration (Nandi, et al., 1997). In addition, we found complete replacement of ?5 in WT 
MEFs constitutively expressing ?5i-Flag protein, which supports the idea of preferential 
integration of immunosubunits. However, according to our concept, higher affinity of 
immunosubunits would only accelerate the replacement of constitutive subunits and explains 
why i20S can form rapidly after infection. 
In summary, our results demonstrate that the model of cooperative proteasome assembly must 
be revised. Instead, we suggest that simultaneous overexpression of all three immunosubunits, 
which consequently leads to the replacement of constitutive subunits at protein level, is an 
important mechanism of i20S formation. In this competition, high affinity of immunosubunits 
to assembling proteasome comlexes seems to further facilitate their rapid integration.  
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4.1.2 ?5 is a limiting factor for proteasome maturation in lmp7-/- 
mice 
 
We demonstrated that in infected lmp7
-/-
 mice ?5 is preferentially integrated into m20S and 
could not find evidence for specific integration into c20S. Still, the accumulation of precursor 
proteasomes containing pre-?1i and pre-?2i points at impaired maturation of 20S complexes 
in lymphoid or infected tissues of lmp7
-/-
 mice.  
According to cooperative proteasome assembly, ?5i deficieny is sufficient to induce an 
accumulation of precursor proteasomes, because it is crucial for efficient maturation of ?1i 
and ?2i in T2 cells (Griffin, et al., 1998; Kingsbury, et al., 2000). However, that the 
accumulation of precursor proteasomes may be caused by a shortage of ?5 subunits in 
lymphoid or infected tissues has been barely considered.  
Here, we provide data suggesting a limitation of ?5. First, compared to WT mice the 
abundance of ?5 is constitutively increased in the spleens of lmp7-/- mice. Second, the amount 
of ?5 remained constant in the livers of lmp7-/- mice, while the abundance of this subunit 
declined during infection of WT mice. However, in both organs the amount of ?5 remained 
unaltered in infection, indicating that its usage was already maximal. In agreement with this 
finding, we did not detect free ?5 subunits or ?5 bound to precursor proteasomes of lmp7-/- 
mice. These results support the assumption that the availability of ?5 is a limiting factor for 
20S proteasome assembly in lmp7
-/-
 mice.  
Further, we showed that the mRNA expression of ?5 was not upregulated in lmp7-/- mice in 
order to compensate for the deficiency of ?5i. However, the transcriptional level of ?5 was 
much higher in the liver as compared to the spleen and may explain, why ?1i and ?2i were 
more efficiently integrated in the liver of lmp7
-/-
 mice. In conclusion, we assume that the 
limitation of ?5 is set at the transcriptional level, which consequently results in the varying 
integration-efficiency of ?1i and ?2i in lymphoid and non-lymphoid tissues of lmp7-/- mice. 
Noteworthy, T2 cells are of lymphoid origin with presumably low expression of ?5, which 
could explain the strong accumulation of pre-?1i and pre-?2i in T2 cells reconstituted with 
lmp2 but not lmp7.  
Also other groups showed that the transcription of ?5 is a limiting factor for proteasome 
assembly, as overexpression of ?5 could increase the total amount of proteasomes per cell 
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(Chondrogianni, et al., 2005; Das, et al., 2007; Liu, et al., 2007). However, the impact of ?5 
on the integration of ?1i and ?2i was not analysed in these studies.  
Indeed, overexpression of ?5 in lmp7-/- MEFs facilitates the maturation of ?1i and ?2i and 
accelerated proteasome neosynthesis was confirmed by increased POMP turnover. Especially 
the integration of ?2i was substantially improved albeit with slower kinetics than in WT 
MEFs. In contrast, the integration of ?1i was only marginally increased. This is in agreement 
with the work of Kingsbury et al., who showed that overexpression of ?5 in T2 cells 
reconstituted with lmp2 cannot substantially improve the integration of ?1i. However, the 
effect on the integration of ?2i was not analysed in this study (Kingsbury, et al., 2000). 
In summary, our results demonstrate that the availability of ?5 in lmp7-/- mice is limiting for 
the integration of ?1i but especially of ?2i. However, the large proportion of precursor 
proteasomes in lmp7
-/-
 MEFs despite strong overexpression of ?5 indicates that other factors 
than mere quantity must be involved in the regulation of ?5-integration in 20S complexes. 
 
4.1.3 POMP regulates the integration efficiency of ?5 and ?5i 
 
The strong accumulation of precursor proteasomes in lmp7
-/-
 cells despite overexpression of 
?5 raised the question, which factors regulate the differential integration efficiency of ?5 and 
?5i.  
In yeast, the proteasome maturation factor Ump1p is required for proper maturation of 20S 
proteasomes. Interestingly, deficiency in Ump1p allows integration of ?5 with a deleted 
prosequence while presence of Ump1p inhibits it. Therefore, an Ump1p dependent checkpoint 
in proteasome assembly, which controls the integration of ?5 on the basis of its propeptide, 
has been postulated (Ramos, et al., 1998). In addition, it was recently shown that the 
interaction of Ump1p with pre-?5 stabilizes the 16S precursor dimer and thus allows efficient 
maturation of 20S proteasomes (Li, et al., 2007). Hence, it is conceivable that similar to 
Ump1p its mammalian homologue POMP might regulate the integration of ?5 and ?5i. 
Accordingly, POMP was shown to interact with both subunits in mammalian cells (Fricke, et 
al., 2007; Heink, et al., 2005; Jayarapu and Griffin, 2004; Witt, et al., 2000). 
It is known that incorporation of ?5 or ?5i occurs late in the formation of half proteasomes 
(Nandi, et al., 1997). We found accumulation of POMP in precursor proteasomes, which were 
devoid of ?5 subunits in lmp7-/- mice. This indicates that POMP binds to precursor 
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proteasomes before ?5 or ?5i are integrated, which is a prerequisite to control their access to 
assembling proteasome complexes. Accordingly, it was recently shown that POMP already 
binds to ?-rings and can interact with all ?-subunits indicating that it recruits these subunits to 
assembling proteasome complexes (Fricke, et al., 2007). Thus, we suggest that similar to 
Ump1p in yeast, POMP controls the integration of ?5 and ?5i in mammalian cells. 
Although ?5 and ?5i can bind to POMP independent of their propeptides, Heink et al. 
suggested that the prosequences mediate differential interaction of these subunits with POMP 
(Heink, et al., 2005). In agreement with this, integration of ?5 is improved, when its 
propeptide is exchanged against that of ?5i. In contrast, fusion of the ?5-propeptide to ?5i 
diminishes the integration of the chimeric protein (Kingsbury, et al., 2000). Also deletion of 
the ?5i-prosequence results in impaired proteasome maturation (Witt, et al., 2000) and the ?5i 
isoform LMP7E1, which carries a different prosequence compared to the major isoform 
LMP7E2, is barely integrated into 20S proteasomes (Heink, et al., 2006). In addition, 
interaction analysis with a yeast two-hybrid screen indicated higher affinity of ?5i to POMP 
compared to ?5 (Fricke, et al., 2007). 
In summary, it can be concluded that the differential interaction of ?5 and ?5i with POMP 
regulates the rate of proteasome assembly, which is most likely a function of their 
prosequences. In this process, rapid recruitment of ?5i by POMP promotes accelerated 
proteasome assembly and facilitates i20S formation. In contrast, slow recruitment of ?5 by 
POMP limits the assembly rate of m20S in lmp7
-/-
 mice and therefore is responsible for the 
accumulation of precursor proteasomes observed in these mice. Finally, limited recruitment of 
?5 by POMP might explain why overexpression of this subunit in lmp7-/- MEFs can restore 
integration of ?2i only with slow kinetics.  
 
4.1.4 Regulation of the proteasome content  
 
So far, the regulation of the cellular proteasome content in mammalian cells is largely 
unknown. In yeast, the amount of proteasomes is regulated by the transcription factor Rpn4, 
which drives the transcription of all proteasomal subunits by a PACE sequence in their 
promoters. Rpn4 itself is a proteasomal substrate, thus the amount of proteasomes is kept 
constant by a feedback loop between Rpn4-synthesis and its proteasomal degradation 
(Dohmen, et al., 2007).  
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It has been shown that treatment of cell cultures with proteasome inhibitors leads to the 
concerted expression of proteasomal subunits as well as POMP, which indicates that such a 
feedback-loop could also exist in mammalian cells (Meiners et al., 2003). Indeed, the 
transcription factor Nrf2 was shown to induce the transcription of most proteasome subunits 
via an antioxidant response element (ARE) in their promoters (Kwak, et al., 2002; Kwak, et 
al., 2003). However, Nrf2 also induced the expression of ?1, ?2 and ?5, while we found 
unaltered expression of these subunits in infection. This suggests that Nrf2 is not involved in 
the upregulation of proteasome content in infection.  
Our results demonstrate that the induction of ?5i is crucial for the upregulation of proteasomal 
content in WT mice, because the amount of proteasomes remained constant in infected lmp7
-/-
 
mice. In addition, the proteasome quantity was constitutively decreased in lmp7
-/-
 compared to 
WT mice. This suggests that a feedback-loop like in yeast does not exist in mammals, because 
it would counterbalance the reduced amount of proteasomes in lmp7
-/-
 mice as well as the 
upregulation of proteasomes in WT mice to maintain proteasome homoeostasis.  
Instead, we propose that the high affinity of ?5i to POMP does not only mediate accelerated 
proteasome assembly as reported previously (Heink, et al., 2005), but also drives the 
upregulation of proteasome content in infection. In contrast, the slow recruitment of ?5 by 
POMP results in a constant turnover of proteasomes resulting in homoeostasis under steady 
state conditions. Consequently, the balance of POMP and ?5 determines the amount of 
proteasomes under homoeostatic conditions. This is supported by the observation, that 
overexpression of either ?5 or POMP, is capable to increase the cellular proteasome content, 
because both will shift the balance towards accelerated proteasome assembly (Chondrogianni 
and Gonos, 2007; Chondrogianni, et al., 2005; Das, et al., 2007; Liu, et al., 2007). 
The expression of POMP is IFN?-inducible in vitro, which is thought to promote the rapid 
neogenesis of i20S (Burri, et al., 2000; Heink, et al., 2005; Witt, et al., 2000). Although we 
observed an IFN? dependent upregulation of immunosubunits following Listeria infection 
(Strehl, et al., 2006), we did not detect a significant increase in POMP mRNA expression 
neither in spleen nor liver. This demonstrates that induction of POMP is not involved in the 
upregulation of proteasomal content following infection. Accordingly, reconstitution of T2 
cells with ?5i is sufficient to increase the rate of proteasome assembly independent of IFN? 
(Heink, et al., 2005). Still, it cannot be excluded that simultaneous induction of all three 
immunosubunits is necessary to increase the amount of proteasomes per cell. 
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Besides expression of IFN? inducible subunits, upregulation of the cellular proteasome 
content requires that either all structural subunits of the 20S complex are constitutively 
produced in excess or that their expression is induced by infection. However, it was shown 
that overexpression of ?5 is sufficient for the upregulation of proteasome content in different 
cell types (Chondrogianni et al., 2005; Liu et al., 2007). This implies constitutive 
overproduction of the structural subunits, which could be a mechanism to allow rapid 
neogenesis of proteasomes under cellular stress, e.g. in infection.  
 
4.1.5 Model of competitive integration of catalytic ?-subunits in 
20S proteasome assembly 
 
Although our data strongly challenge the model of cooperative proteasome assembly (Fig.II; 
(Griffin, et al., 1998; Kingsbury, et al., 2000), we still think that c20S and i20S are the most 
abundant proteasome forms in WT animals and that only a smaller fraction occurs as mixed 
20S proteasomes. In the following, we present a new model of 20S proteasome assembly that 
explains the formation of c20S or i20S by competitive integration of the catalytic ?-subunits. 
This model further decribes the regulation of the cellular proteasome content by expression of 
constitutive or immunosubunits (Fig. III). 
Naive, non-lymphoid tissues display high expression of the constitutive subunits while that of 
immunosubunits is low (Kuckelkorn, et al., 2002). Hence, under these conditions 
predominantly c20S are generated. Further, we assume that POMP controls the rate of ?5-
integration resulting in a constant turnover of 20S complexes (Fig. IIIA).  
In infected or inflamed tissues immunosubunits are simultaneously expressed at high levels, 
while the expression of the constitutive subunits remains unaltered. This enables the 
immunosubunits to oust the constitutive subunits, which consequently results in the formation 
of i20S (Fig. IIIB).  
Although we also detected signs of competitive integration in the spleen, mere mass action 
cannot explain the predominant integration of immunosubunits in lymphoid tissue. Especially, 
the expression of ?2i is low in naive spleens as compared to ?2. However, as previously 
discussed ?1i and ?2i mutually facilitate their integration in 20S proteasomes (Groettrup, et 
al., 1997). Thus, we propose that the high constitutive expression of ?1i promotes the 
integration of ?2i in lymphoid tissue.  
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Figure III. The model of competitive integration of catalytic ?-subunits during proteasome assembly 
Shown are the events that lead to the formation of c20S (A) or i20S (B) according to the model of competitive 
integration of catalytic ?-subunits.  
 
 
Immunosubunits were shown to possess higher affinity to assembling proteasome complexes 
as compared to constitutive subunits, which is a function of their propeptides (De, et al., 2003; 
Kingsbury, et al., 2000; Nandi, et al., 1997). In our model of competitive integration, the high 
affinity of immunosubunits to assembling proteasome complexes means a substantial 
advantage for their integration and thus contributes to the replacement of c20S by i20S.  
Recently, various forms of proteasome subtypes with mixtures of constitutive and 
immunosubunits have been identified (Klare, et al., 2007). Formation of mixed proteasomes 
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can be easily explained by competitive integration, because it is likely that these subtypes 
arise in a situation in which neither the expression of constitutive nor immunosubunits 
predominates. 
Further, we suggest that the strong interaction of ?5i and POMP does not only accelerate the 
assembly of 20S proteasomes to aid the rapid neogenesis of i20S (Heink, et al., 2005), but 
also promotes the transient upregulation of cellular proteasome content in infection. This 
increase in proteasome quantity during infection might be important for the defence against 
oxidative stress, activation of NF-?B and optimal MHC class I antigen presentation (Fig. 
IIIB).  
In contrast, in lmp7
-/-
 mice the slower proteasome assembly rate in the presence of ?5 cannot 
cope with the strong neosynthesis of precursor proteasomes induced in infection. 
Accordingly, an accumulation of precursor proteasomes with impaired maturation of ?1i and 
?2i and reduced cellular proteasome content is observed in these mice (Fig. IV). 
 
 
 
 
Figure IV. The model of competitive proteasome assembly applied to lmp7
-/-
 mice 
Shown are the events that lead to the accumulation of precursor proteasomes and the formation of m20S in  
lmp7
-/-
 mice according to the model of competitive integration of catalytic ?-subunits. 
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4.2 The effects of ?5i-deficiency on the immune response 
against Listeria 
 
A central question of this thesis is how ?5i-deficiency impacts the immune response against 
Listeria monocytognes. The major phenotype of lmp7
-/-
 mice is the reduced MHC class I 
surface expression caused by a lack of peptides produced by the proteasome system (Fehling, 
et al., 1994). In addition, we know that efficient generation of the listerial epitope LLO296-304 
depends on the activity of i20S (Strehl, et al., 2006). Thus, we wondered wether presentation 
of LLO296-304 is impaired in Listeria-infected lmp7
-/-
 mice. As antigen presentation can be 
limiting for priming and expansion of CD8
+
 effector T cells (Wong and Pamer, 2003), we also 
studied if the LLO296-304 specific CD8
+
 T cell response is impaired in these mice. Further, we 
were interested in the impact of ?5i-deficiency on bacterial control.  
 
4.2.1  Reduced MHC class I antigen presentation in lmp7-/- mice 
is not limiting for CD8+ T cell priming 
 
Presentation of peptides on MHC class I molecules is a highly inefficient process, in which 
less than 0.01% of peptides generated by proteasomes are presented on the cell surface 
(Yewdell, et al., 2003). i20S are believed to facilitate antigen processing, because the 
generation of peptides with suitable anchor residues for MHC class I binding is increased 
(Groettrup, et al., 2001). This altered cleavage site specificity of i20S also results in improved 
generation of the correct C-terminus of the epitope LLO296-304, while resulting in fewer 
cleavages, which destroy the epitope (Strehl and Kloetzel, unpublished results).  
An increase in antigen presentation in the presence of i20S was described for a variety of 
epitopes (Kuckelkorn, et al., 1995; Kuckelkorn, et al., 2002; Sijts, et al., 2000; Sijts, et al., 
2000). However, i20S do not generally improve epitope processing as others are inefficiently 
presented in their presence (Basler, et al., 2004; Chapiro, et al., 2006; Van den Eynde and 
Morel, 2001). Still, the reduced MHC class I surface expression of lmp7
-/-
 mice suggests that 
the function of i20S is crucial for efficient presentation of the majority of antigens. 
Particularly, the restored MHC class I presentation by the exogenous adminstration of 
peptides demonstrates that the amount of epitopes is limited in lmp7
-/-
 mice (Fehling, et al., 
1994).  
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According to the concept of cooperative i20S assembly, the reduced MHC class I expression 
in lmp7
-/-
 mice is caused by a general lack of immunosubunits (Griffin, et al., 1998). 
However, our results reveal considerable integration of ?1i and ?2i in m20S. Still, the MHC 
class I surface expression was reduced on professional APCs of infected lmp7
-/-
 mice. Further, 
processing of the LLO-substrate was not restored by the induction of m20S, indicating that 
the specific activity of ?5i is required for generation of the LLO296-304 epitope. This is in 
contrast to the finding that presentation of some epitopes on ?5i deficient cells was restored 
by overexpression of an inactive ?5i subunit (Gileadi, et al., 1999; Sijts, et al., 2000). Further, 
m20S isolated from the spleen of lmp7
-/-
 mice display a 3fold enhanced chymotryptic activity 
compared to i20S (Stohwasser, et al., 1996). In conclusion, these findings suggest that the 
catalytic activity of ?5i itself is not critical for i20S function. Instead, the structural alterations 
that it introduces to the 20S complex seem to be critical for optimal i20S activity (Sijts, et al., 
2000). Accordingly, Kisselev et al. have previously described an allosteric regulation between 
catalytic ?-subunits, which is based on structural alterations in the cavity of the 20S complex 
(Kisselev, et al., 1999). Still, it is currently not clear whether the intrinsic catalytic activity of 
?5i or its structural impact is responsible for improved LLO296-304 epitope generation by i20S. 
We found an upregulation in the amount of proteaomes following infection of WT mice, 
which is abrogated in lmp7
-/-
 mice. Interestingly, the reduction in MHC class I surface 
expression of 25-40% directly correlates with the 25-40% reduced proteasome content in 
lymphoid and infected tissue of lmp7
-/-
 mice. This suggests that not only improved cleavage 
site specificity and enhanced substrate turnover by i20S facilitates MHC class I antigen 
presentation, but that also the amount of proteasomes substantially contributes to this process. 
Accordingly, inhibition of POMP expression by siRNA, which leads to a reduction in the 
cellular proteasome content, was shown to decrease the MHC class I surface expression 
(Heink, et al., 2005). 
As previously discussed, we assume that the upregulation of the cellular proteasome content 
is achieved by accelerated recruitment of ?5i by POMP. Considering these results, restored 
antigen presentation by expression of a catalytically inactive ?5i subunit may also be 
explained by the upregulation of proteasomes induced by this subunit. This finding might 
explain why MHC class I surface expression is reduced in lmp7
-/-
 but not lmp2
-/-
 or mecl1
-/-
 
mice. 
However, for the in vitro processing of the LLO-substrate same amounts of purified 20S 
proteasomes were used. Still, m20S isolated from lmp7
-/-
 mice were inefficient in generating 
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the LLO296-304 epitope. This demonstrates that presentation of the LLO296-304 epitope in lmp7
-/-
 
mice is affected in two ways: By reduced proteasome quantity and the lack of specific i20S 
activity. 
Previous reports analysed the impact of immunosubunit-deficiency on CD8
+
 T cell responses 
in infection. It was shown that ?1i-deficiency influences the immunodominance hierarchy and 
the repertoir of CD8
+
 T cells responding to influenza virus infection (Chen, et al., 2001). 
Similar results were found in mecl1
-/-
 mice, which also display an altered T cell repertoire and 
thus reveal decreased CD8
+
 T cell frequencies in response to Lymphocytic choriomeningitis 
virus (LCMV) infection (Basler, et al., 2006). However, LCMV infection of lmp2
-/-
 and lmp7
-
/-
 mice revealed only minor differences in CD8
+
 T cell frequencies and immunodominance 
hierarchies compared to WT mice (Nussbaum, et al., 2005).  
While these reports focused on viral infection models, we investigated the impact of ?5i-
deficiency on CD8
+
 T cell responses in a bacterial infection. Due to the escape of Listeria into 
the host cell cytosol, clearance of the bacteria depends on the activation of pathogen specific 
CD8
+
 T cells (Ladel, et al., 1994). In contrast to virus-infected cells, which are forced to 
produce high amounts of viral proteins (Buchmeier, et al., 1980), Listeria secrete only few 
proteins into the host cell cytosol. One of these proteins, LLO, is secreted for lysis of the 
phagosome and subsequently down-regulated as continuous secretion would be toxic for the 
host cell (Villanueva, et al., 1995). Due to the limited secretion of bacterial proteins, efficient 
processing of these antigens is critical compared to viral infection. 
However, the magnitude of a CD8
+
 T cell response is only minimally affected by the 
abundance of antigenic peptides on infected cells (Vijh, et al., 1998). When antigens are 
presented above a certain threshold within the first 48 h of infection, priming and expansion 
of CD8
+
 T cells is largely independent of further antigen presentation (Badovinac, et al., 
2002; Mercado, et al., 2000; Wong and Pamer, 2003).  
Here, we detected reduced MHC class I surface expression on professional APCs of lmp7
-/-
 
mice within the first 48 h of infection and impaired processing of LLO. Thus, we anticipated 
that the threshold of antigen presentation necessary for priming of LLO296-304 specific CD8
+
 T 
cells is not overcome in lmp7
-/-
 mice.  
Suprisingly, we could not detect any differences in LLO296-304 specific CD8
+
 T cell 
frequencies between WT and lmp7
-/-
 mice. This shows, that reduced proteasomal processing 
and presentation of LLO296-304 in lmp7
-/-
 mice is not limiting for priming of LLO296-304 specific 
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CD8
+
 T cells, which agrees with the results derived from LCMV infection (Nussbaum, et al., 
2005).  
In contrast, it was shown that expression of ?5i is essential for efficient cross priming of 
CD8
+ 
T cells in a skin graft rejection model. In this report, Palmowski et al. demonstrated that 
WT male skin grafts were not rejected by female lmp7
-/-
 mice due to impaired priming of 
CD8
+
 T cells directed against the male, immunodominant HY epitope Uty246-254. Generation 
of this epitope is dependent on the specific activity of i20S (Palmowski, et al., 2006). 
Another study demonstrated impaired priming of CD8
+
 T cells in lmp7
-/-
 x mecl1
-/-
 mice. 
Here, a recombinant Listeria strain secreting the two model antigens E1B192-200 and E1A234-243 
was constructed. While processing of E1B192-200 was shown to be i20S dependent, E1A234-243 
is processed i20S independent. Accordingly, only priming of E1B192-200 but not E1A234-243 
specific CD8
+
 T cells is abrogated in lmp7
-/-
 x mecl1
-/-
 mice. This deficit in priming of  
E1B192-200 specific CD8
+
 T cells was caused by delayed presentation of the corresponding 
epitope, as the treshold of antigen necessary for efficient priming was not achieved in the 
critical time frame (Deol, et al., 2007).  
Further, in chimeric HLA-A2 x lmp7
-/-
 mice, the CD8
+
 T cell response directed against two 
immunodominant epitopes of hepatitis B virus was substantially decreased compared to HLA-
A2 x lmp7
+/- 
littermates, whereas CD8
+
 T cell frequencies against a subdominat epitope were 
increased (Robek, et al., 2007).  
In summary, these reports reveal, that i20S or specific immunosubunits are not generally 
dispensable for CD8
+
 T cell priming. However, taken our results into account, we conclude 
that the influence of i20S or distinct catalytic ?-subunits on epitope processing and CD8+ T 
cell priming must be elucidated individually for each analysed epitope.  
 
4.2.2 Impaired recognition of non-lymphoid target cells in lmp7-/- 
mice 
 
Clearance of Listeria depends on the activity of CD8
+
 T cells (Ladel, et al., 1994). The 
infection experiments demonstrated delayed clearance of the bacteria in lmp7
-/-
 mice. 
Interestingly, the deficit during late bacterial control was detected in the liver but not the 
spleen, although the frequencies of LLO296-304 specific CD8
+
 T cells in both organs were 
similar to WT mice. However, normal clearance of Listeria in the spleen of lmp7
-/-
 mice 
suggests that the intrinsic function of CD8
+
 T cells is not affected in these mice.  
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While in the spleen, Listeria predominantly infect M? and DCs, hepatocytes are the main 
host cell in the liver (Gregory, et al., 1992). In contrast to DCs and M?, which are 
professional APCs and consequently display a high MHC class I surface expression, non-
lymphoid cells like hepatocytes have to upregulate their MHC class I antigen presentation 
machinery in response to infection. Important mediators of MHC class I induction in infection 
are interferons. However, Chen et al. revealed that MHC class I surface expression is 
remarkably high on naive hepatocytes and comparable to splenocytes. Still, upregulation of 
the MHC class I presentation machinery including induction of ?5i is observed following 
IFN? stimulation of hepatocytes (Chen, et al., 2005).  
As naïve hepatocytes were shown to be tolerogenic (Crispe, 2003), it is believed that IFN?- 
stimulation enables CD8
+
 T cell mediated cytolysis of hepatocytes (Chen, et al., 2005). 
Interestingly, recently primed CD8
+
 T cells themselves induce MHC class I expression on 
hepatocytes by secretion of IFN? (Dikopoulos, et al., 2004). Further, elimination of 
recombinant adenovirus infected hepatocytes by CD8
+
 T cells was shown to depend on 
IFN? secretion by TH1 CD4+ T cells (Yang, et al., 1995). In accordance, infection of IFN? 
receptor deficient mice demonstrated that induction of i20S in the liver is strictly IFN? 
dependent (Strehl, et al., 2006).  
As previously discussed, induction of i20S facilitates MHC class I surface expression by 
improved cleavage site specificity and enhanced cellular proteasome content. As these 
mechanisms are abrogated in lmp7
-/-
 mice, we suggest that delayed clearance of Listeria in the 
liver of lmp7
-/-
 mice is caused by impaired recognition and lysis of infected hepatocytes by 
CD8
+
 T cells.  
In agreement, it was shown in a model of autoimmune type I diabetes that lysis of 
parenchymal pancreatic islet cells by CD8
+
 T cells depends on the induction of MHC class I 
surface expression mediated by LCMV infection and subsequent IFN?/? secretion (Lang, et 
al., 2005). However, the impact of i20S induction on MHC class I surface expression, which 
occurs in the liver following LCMV and Listeria infection (Khan, et al., 2001), was not 
analysed in this report.  
In contrast to Listeria, clearance of LCMV infection is not affected in lmp7
-/-
 mice 
(Nussbaum, et al., 2005). However, this might be explained by the strong expression of viral 
proteins by the host cell (Buchmeier, et al., 1980), which consequently results in high 
amounts of viral CD8
+
 cell epitopes. Thus, antigen presentation on LCMV infected 
hepatocytes might not be limiting for recognition by CD8
+
 T cells. 
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Further, LCMV elicits a strong CD8
+
 T cell response against various epitopes in the H2
b
 
background, i.e. peak frequencies of 10-30% directed against the immunodominant epitopes 
GP33 and NP396. In addition, frequencies of 0.5-8% are specific for the subdominant 
epitopes GP276, GP92, GP34 and NP205 (Fuller, et al., 2004; Murali-Krishna, et al., 1998; 
van der Most, et al., 1998). For comparison, the LLO296-304 specific CD8
+
 T cell response with 
peak frequencies of about 0.5% is the strongest in Listeria infection (Geginat, et al., 2001). 
Therefore, the high frequencies of LCMV-specific CD8
+
 effector T cells, which are not 
affected in lmp7
-/-
 mice (Nussbaum, et al., 2005), might compensate for the reduced MHC 
class I antigen presentation on non-lymphoid cells by high effector-to-target ratios. 
Accordingly, Jiang et al. have shown that Listeria-infected hepatocytes are lysed by MHC 
class I restricted CD8
+ 
T cells independently of IFN? stimualtion in vitro (Jiang, et al., 1997), 
which might also depend on high effector-to-target ratios and strong presentation of 
immunodominant T cell epitopes.  
The clearance of Listeria in the liver of lmp7
-/-
 mice was only two days delayed. However, it 
cannot be excluded that other immune defence mechanisms compensate for the impaired 
recognition of Listeria-infected cells by CD8
+
 T cells. Accordingly, the function of MHC 
class Ib restricted CD8
+
 T cells is most likely not affected by ?5i-deficiency, as we found 
unaltered surface expression of H2-M3. These MHC class Ib restricted CD8
+
 T cells were 
shown to provide protection against Listeria infection in mice deficient in the classical MHC 
class I molecules H2K
b
 and H2D
b
 (Seaman, et al., 2000).  
Further, Listeria induce apoptosis of hepatocytes, which attracts neutrophils to eliminate 
extracellular bacteria (Rogers, et al., 1996) and allows cross presentation of bacterial antigens 
on professional APCs. However, cross presentation on APCs could compensate for 
insufficient MHC class I antigen presentation on hepatocytes. 
In summary, we suggest that the induction of i20S in non-lymphoid tissue is crucial for 
efficient upregulation of MHC class I surface expression on infected cells, which then enables 
their recognition and lysis by effector CD8
+
 T cells. In contrast, the MHC class I antigen 
presentation on lymphoid cells of lmp7
-/-
 mice seems to be sufficient for recognition by CD8
+
 
T cells. Unfortunately, attempts to prove inefficient cytolysis of non-lymphoid target cells 
derived from lmp7
-/-
 mice failed due to technical limitations.  
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4.2.3 Possible influences of ?5i-deficiency on innate immune 
defence mechanisms in Listeria infection 
Besides delayed clearance of Listeria in the liver, the early bacterial control was impaired in 
lmp7
-/-
 mice. As this suggests a defect in innate immune defence, we will discuss how ?5i-
deficiency could affect innate immune defence mechanisms. 
Following intravenous inoculation most bacteria are filtered from the bloodstream by Kupffer 
cells in the liver and are rapidly killed by immigrating neutrophils (Cousens and Wing, 2000; 
Gregory, et al., 1996). However, the surviving Listeria start to replicate within hepatocytes. 
The bacterial titers reach a plateau 3-4 days post infection, because their replication is 
controlled by various innate defence mechanisms (Gregory, et al., 1992; Mackaness, 1962).  
NKT cells participate in the early immune response against Listeria (Ranson, et al., 2005), but 
an impact of ?5i-deficiency on the CD1d restricted NKT cells can be largely excluded as they 
react to lipid antigens, which are not processed by the proteasome.  
H2-M3 deficient mice were shown to exhibit a similar phenotype with increased listerial titers 
3-4 days post infection in spleen and liver (Xu, et al., 2006). Since, we found unaltered H2-
M3 surface expression in lmp7
-/-
 compared to WT mice, the MHC class Ib restricted CD8
+
 T 
cell response is most likely not impaired. Thus, we speculate that other innate immune 
defence mechanisms are affected by ?5i-deficiency.  
An important early effector mechanism of innate immunity is the synthesis of 
proinflammatory cytokines, such as IL-1, IL-6, IL-12 and TNF?. These cytokines, e.g. recruit 
neutrophils and activate NK cells to release IFN? (Cousens and Wing, 2000). In hepatocytes, 
IFN? induces antibacterial mechanisms synergystically with IL-6 and TNF? and at the same 
time activates M?. Whereas hepatocytes exert their bactericidal effects primarily by secretion 
of reactive oxygene intermediates (ROI) (Gregory and Wing, 1993; Szalay, et al., 1995), M? 
attack Listeria by production of reactive nitrogen intermediates (RNI) (MacMicking, et al., 
1995). In the spleen, a population of TNF? and iNOS producing DCs (TipDCs) was found to 
substantially contribute to control of listerial growth by RNI secretion (Serbina, et al., 2003). 
Thus, the oxidative burst is an important effector mechanism that restricts bacterial 
replication. 
We detected reduced secretion of IL-6 and TNF? by Listeria infected lmp7-/- compared to WT 
BM-M?. As these cytokines are involved in the induction of the oxidative burst, we speculate 
that this defence mechanism may be impaired in lmp7
-/-
 mice. Accodingly, mice that lack IL-6 
or TNF? reveal impaired control of Listeria (Dalrymple, et al., 1995; van Furth, et al., 1994). 
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Another possibility is that the oxidative burst itself is involved in the increased susceptibility 
of lmp7
-/-
 mice to Listeria infection, because removal of toxic, oxidated proteins is a function 
of the ubiquitin-proteasome pathway.  
It was shown that in endothelial cells ?1i and ?5i are inducible by NO, presumably as an 
antioxidative defence mechanism (Kotamraju, et al., 2006). Indeed, lmp2
-/-
 mice revealed an 
accumulation of oxidatively damaged proteins, suggesting that the increased chymotryptic 
activity of i20S facilitates the removal of such proteins (Ding, et al., 2006). Further, we 
demonstrated an increase in cellular proteasome content following induction of i20S and it 
was reported that the upregulation of proteasome content enhances the resistance to oxidative 
stress (Chondrogianni, et al., 2003; Chondrogianni, et al., 2005; Liu, et al., 2007). Thus, 
reduced chymotryptic activity and impaired upregulation of the proteasome system could 
result in an impaired antioxidative stress response in lmp7
-/-
 mice, which could consequently 
result in increased tissue damage and enhanced bacterial titers.  
 
The expression of IL-6 and TNF? is controlled by the NF-?B transcription factor family and 
proteasomes are involved in the activation of NF-?B. It has been shown that especially the 
chymotrypsin-like activity of proteasomes is essential for efficient processing of p105 and 
degradation of I?B? (Petrof, et al., 2004). Accordingly, splenocytes of lmp2-/- mice and the 
?1i and ?5i deficient T2 cells revealed reduced NF-?B activation following TNF? stimulation 
(Hayashi and Faustman, 1999; Hayashi and Faustman, 2000). Although these results were 
controversially discussed in the literature (Runnels, et al., 2000), further evidence for a role of 
i20S in NF-?B activation comes from our own work. We could show increased turnover of 
I?B and improved processing of p105 by proteasomes isolated from patients with 
inflammatory bowel disease (IBD) in vitro. As these proteasomes predominantly contained 
i20S, we found a positive correlation between increased levels of i20S and enhanced NF-?B 
activation in IBD (Visekruna, et al., 2006).  
In addition, a reduction in cellular proteasome content in aging cells was shown to affect the 
activation of NF-?B (Carrard, et al., 2002). 
Thus, induction of i20S can influence NF-?B activation by increased chymotryptic activity 
and enhanced cellular proteasome content. As both processes are impaired in lmp7
-/-
 mice, a 
reduced activation of NF-?B following Listeria infection is conceivable. However, the 
function of NF-?B is essential for the antilisterial immune defence (Edelson and Unanue, 
2002; Sha, et al., 1995; Weih, et al., 1997). In conclusion, reduced NF-?B activation may be 
responsible for impaired innate immunity in lmp7
-/-
 mice during Listeria infection.  
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Abbreviations 
?g microgramm 
?l microlitre 
?M micromolar 
?m micrometre 
2D two dimensional 
AMC 7-Amido-4-Methylcoumarin 
APC antigen presenting cell 
ATP adenosine-tri-phosphate 
BM-M? bone marrow macrophages 
c20S constitutive proteasome 
CD cluster of differentiation 
cDNA copy desoxyribonucleic acid 
cfu colony forming unit 
cm centimetre 
CO2 carbondioxide 
C-terminal carboxy-terminal 
DC dendritic cell 
DDM N-dodecyl D-maltoside 
DEAE diethylaminoethyl 
DMEM Dubelccos Modified Eagle Medium 
DNA desoxyribonucleic acid 
DRiPs defective ribosomal products 
DTT dithiothreitol 
EDTA ethylendiamin tetra acetate 
e.g. for example 
ER endoplasmatic reticulum 
FACS fluorescence activated cell sorting 
FCS fetal calf serum 
Fig. figure 
g acceleration of gravity 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
h hours 
i.e. that means 
i.v. intraveniously 
i20S immunoproteasome 
ICS intracellular cytokine staining 
IFN Interferon 
IgG immunoglobulin G 
I?B inhibitor of kappa B 
IL interleukin 
kDa kilo-Dalton 
LC-ESI-MS liquid chromatography-electrospray ionization-ion trap mass 
spectrometry 
LCMV Lymphocytic choriomeningitis virus 
Listeria Listeria monocytogenes 
LLO Listeriolysin O 
lmp- low molecular mass peptide 
LTR long terminal repeat 
Lys lysine 
m20S mixed proteasomes 
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mA milli-Ampere 
mecl- multicatalytic endopeptidase complex-like- 
MEFs murine embryonic fibroblasts 
M? macrophages 
MHC major histocompatibility complex 
min minute 
ml millilitre 
mM millimolar 
MPIIB Max Planck Institute for Infection Biology 
mRNA messenger ribonucleic acid 
MSCV Murine Stem Cell Virus 
NaCl Sodium Chloride 
NADPH Nicotinamide adenine dinucleotide phosphate 
NaN3 sodium azide 
NF-?B Nuclear Factor kappa B 
NH4Cl ammonium chloride 
NK cell natural killer cell 
nm nanometre 
NO nitric oxide 
N-terminal amino-terminal 
p.i. post infection 
PAC proteasome assembling chaperone 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
pmol picomol 
PMSF phenylmethylsulfonylfluoride 
POMP proteasome maturation protein 
pre- precursor- 
PVDF polyvinylidenfluoride 
RNA ribonucleic acid 
RNI reactive nitrogen intermediates 
ROI reactive oxygen intermediates 
rpm rotations per minute 
RPS9 ribosomal protein subunit 9 
RT reverse transcriptase 
SDS sodiumdodecylsulfate 
sec seconds 
SPF special pathogen free 
t20S thymic proteasomes 
TAP transporter associated with antigen presentation 
TBS Tris buffered saline 
TCR T cell receptor 
TNF tumor necrosis factor 
TPPII tripeptidylpeptidase II 
U units 
UBA ubiquitin associated 
UBL ubiquitin-like 
V Volt 
v/v volume per volume 
w/v weight per volume 
WT wild type  
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